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Amyloid fibrillation is a protein self-assembly phenomenon that is intimately related to well-
known human neurodegenerative diseases. During the past few decades, striking advances have been
achieved in our understanding of the physical origin of this phenomenon and they constitute the
contents of this review. Starting from a minimal model of amyloid fibrils, we explore systematically
the equilibrium and kinetic aspects of amyloid fibrillation in both dilute and semi-dilute limits. We
then incorporate further molecular mechanisms into the analyses. We also discuss the mathematical
foundation of kinetic modeling based on chemical mass-action equations, the quantitative linkage
with experimental measurements, as well as the procedure to perform global fitting.
L.H. and Y.J.H. would like to dedicate this paper to the memory of Prof. Chia-Chiao Lin (1916-2013), a great
applied mathematician, a beloved advisor and a dear friend, on his 100-year anniversary.
List of Symbols
[Ai] Concentration of filaments of size i
[Ci] Concentration of cells in state i
Ns(ns) Number (concentration) of s-mer
N
(β)
s (n
(β)
s ) Number (concentration) of monomers in the beta-sheet configuration
NRs (n
R
s ) Number (concentration) of monomers in the random coil configuration
m Monomer concentration
P Number concentration of total aggregates
M Mass concentration of total aggregates
Poli Number concentration of oligomers
Moli Mass concentration of oligomers
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2mtot Total concentration of proteins
m0 Initial monomer concentration
P0 Initial number concentration of aggregates
M0 Initial mass concentration of aggregates
nc Critical nucleus size for primary nucleation
n2 Critical nucleus size for secondary nucleation
Km Critical saturation concentration for elongation
Ks Critical saturation concentration for secondary nucleation
m∗F Critical fibrillar concentration
m∗M Critical micellar concentration
k+e Rate constant for monomer association
k−e Rate constant for monomer dissociation
kn Rate constant for primary nucleation
k2 Rate constant for surface catalysed secondary nucleation
k+f Rate constant for filaments fragmentation
k−f Rate constant for filaments annealing
k+c Forward reaction rate constant for conformation conversion
k−c Backward reaction rate constant for conformation conversion
k+b Rate constant for membrane binding
k−b Rate constant for membrane unbinding
kapp Apparent fiber growth rate
kmax Maximal fiber growth rate
t1/2 Half-time for fibrillation
tlag Lag-time for fibrillation
3I. INTRODUCTION
The importance of understanding amyloid fibrillation comes not only from its intimate relation to amyloid diseases,
such as the well-known Alzheimer’s, Huntington’s and Parkinson’s diseases [1, 2], but also from its physical simplicity
and universality as a typical self-assembling phenomenon of linear biomolecules [3]. Various thermodynamic and
kinetic approaches borrowed from classical polymer statistical mechanics, the kinetics of chemical reactions as well
as non-equilibrium processes have been developed and applied to experimentally and biologically relevant amyloid
systems with great success [4–6]. Related fruitful results, developments and applications in the past decades constitute
the focus of our current paper: a self-contained review on the thermodynamic and kinetics of amyloid fibrillation.
Thermodynamics and kinetics are two sides of the same coin. The latter deals with time-dependent fibrillation
processes in general; while the former is more focused on the final time-independent properties of the amyloid system
– the equilibrium state. In the current review, we will present the thermodynamics and kinetics of amyloid fibrillation
separately in order to keep each part clear and self-contained. But readers should bear in mind of the intrinsic corre-
lations between those two descriptions, like requirements on reaction rate constants for various fibrillation processes
in order to guarantee the existence of a genuine thermodynamic equilibrium state [7].
The whole review is organized into three major sections. The first one is focused on the thermodynamics of amyloid
fibrillation by using the language of statistical mechanics; the next two are devoted to kinetic descriptions based
on chemical mass-action equations. To be specific, the former provides a systematic exploration of various amyloid
fibrillation processes, including both model formulation and analysis; while the latter is about the mathematical
foundation of kinetic modeling as well as its linkage with experimental observations.
II. STATISTICAL MECHANICS OF AMYLOID FIBRILLATION
Although polymer physics is a well established field of science, novel physics governing the behaviour of the systems
is still being uncovered. In the case of self-assembling biopolymers, the novelty comes from the fact that the binding
energy driving the polymerization process is relatively low compared to covalently bonded polymers. Hence, polymer
breakage and re-joining can potentially contribute to the polymerization kinetics at an experimentally and physiolog-
ically relevant scale. The polymeric system is thus called “living” since every polymer can shrink through breakage
and grow through elongation via monomer additions and through end-to-end joining with another polymer. Taking
these processes into account are important for the complete description of the kinetics of self-assembling polymers.
4In this section, we will focus purely on how a system of living semi-flexible polymers behave at thermal equilibrium.
FIG. 1: (A) A system of spherical particles (beads) with sticky patches on polar ends will self assemble into polymers if the
patches are stickiness enough (B). (C) In the minimal model considered here, the interactions within polymer act as Hookean
springs between the beads to enforce extensile restriction and rigidity. The size of the beads has been shrunken to show the
springs. (D) The specific potential energy functions governing the deviation in extension 4l (solid line) and angle 4θ (broken
line) are assumed to be quadratic.
A. How to construct a minimal model
We will start by considering a minimal model of polymerizing monomers as depicted in Fig. 1A. Namely, the
monomers are purely spherical particles (beads) with two sticky patches at two opposite ends. We assume that the
beads are in an over-damped environment and so their movement is Brownian. The “stickiness” is short-ranged and
is quantitatively described by two quadratic energy functions: one controls the distance between the connected beads
and the other enforces the rigidity of the resulting polymers (Fig. 1C and 1D). We denote the distance between two
connected beads by l0 +4l. Given any consecutive segment of three monomers in a polymer, if the three monomers
5are not co-linear, we denote the angular deviation by 4θ (Fig. 1C). A polymer thus consists of a series of beads such
that for all consecutive pairs of beads, the absolute values of the deviations, |4l|, are smaller than the distance cutoff
lc; and that all deviation angles, 4θ, are also less than the cutoff θc. The energy function for such a s-polymer is then
U({x}) =
s−1∑
k=1
A4l2k +
s−2∑
h=1
B4θ2h − E(s− 1), (1)
where k enumerates the number of distant bonds, h enumerates the number of angular bonds, and E is the binding
energy between the patches that promotes aggregation.
Let us now imagine that at t = 0, we put these monomers in an inert solvent of a certain temperature T (Fig. 1A).
The solvent is inert in the sense that their role in the system is purely to provide the thermalizing effects of a heat
bath. The whole system is further connected to a much larger thermal bath of temperature T in such a way that
heat, but not the beads, can flow back and forth between the system and the large heat bath. In other words, we
are investigating the system from the perspective of a canonical ensemble [8]. The setup of this thought experiment
corresponds to a typical experimental procedure in which polymerising monomers are first dissolved in an appropriate
solvent and then left unperturbed in the course of the experiment. In our case, if the binding energy is strong enough
(i.e., E is large), then we expect that these monomers will self-assemble into polymers (Fig. 1B). Here, we will assume
that the threshold angle θc is small enough that we do not need to worry about the interactions of distant parts of the
same polymer beyond what is already considered in our energy function. In particular, we can ignore the formation
of loops in the system.
Although highly simplified, the model presented here is of relevance to some colloidal systems studied experimentally
[9]. But as we will show, the greatest virtue of this minimal model is its analytical tractability.
B. How to deal with the dilute limit
By the dilute limit, we mean that the concentration of solute and the resulting polymers in the system are dilute
enough that we can ignore all solute interactions except those that lead to polymerization as described in the previous
section. Given this assumption, the free energy density of the overall system can be calculated with the mean-field
method. Specifically, we consider a system of N monomers in a volume V . The total partition function can be written
in terms of the internal partition function of a single s-mer with its first bead’s position fixed in space, zs, in the
following manner [10]:
Ztot =
′∏
s
1
Ns!
(
V zs
Λ3
)Ns
, (2)
6where Ns denotes the number of s-mers in the system and the prime in the product denotes the number conservation
of monomers:
∑∞
s=1 sNs = N . Since we are dealing with “classical” (i.e., not quantum mechanical) objects, the kinetic
part of the partition function (resulting from momentum integrations) is irrelevant [11] and so Ztot corresponds to the
configurational partition function, with Λ being an arbitrary constant of dimension length to make Ztot dimensionless.
The denominator Ns! is in (2) because the s-mers in the system are all indistinguishable and that the free energy
is extensive. Note that these polymers are indistinguishable purely because we have chosen not to distinguish them
in our analysis, which is typically the case in experiments [12].
The total partition function in (2) follows from a mean-field approximation in the sense that the sequence {Ns} is
fixed by minimizing the free energy of the system
Ftot = −kBT logZtot . (3)
In other words, fluctuations away from the minimising sequence {Ns} are ignored. Such an approximation is expected
to be qualitatively correct away from any critical points [8], which, as we shall see, this system does not possess.
To proceed further analytically, we still need to calculate the s-mer partition function zs, which is of the form:
zs =
4pil20e
(s−1)βE
Λ3(s−1)
(∫ lc
−lc
d4le−βA4l2
)s−1(
l20
∫ θc
0
d4θ sin(4θ)e−βB4θ2
)s−2
=
4pi3/2l20e
βE
Λ3
√
βA
(
l20
√
pieβE
Λ3β3/2
√
AB
)s−2
, (4)
for s > 1, while z1 = 1. Note that in (4), the factor 4pil
2
0 comes from integrating over the orientation of the polymer
given that the first bead is fixed in space, the integrals in the first brackets stem from the longitudinal degrees of
freedom and the those in the second brackets from the angular degrees of freedom along the polymer chain. To arrive
at (4), we have taken the limits of integration to infinity, which is legitimate since βA, βB are typically high where
β ≡ kBT .
The total free energy can now be expressed as
Ftot = −kBT
′∑
s
{
Ns log
(
V zs
Λ3
)
− logNs!
}
= −kBT
′∑
s
{
Ns log
(
V zs
Λ3
)
−Ns logNs +Ns
}
= β−1
{
N1
[
logN1 − log V
Λ3
− 1
]
+
′∑
s
Ns
[
logNs − log V
Λ3
− χs− ξ − 1
]}
, (5)
7and
ξ = log
4pi1/2Λ3β5/2A1/2B2
l20
− βE, (6)
χ = log
l20pi
1/2
Λ3β3/2A1/2B
+ βE . (7)
Given (5), we can finally minimise Ftot with respect to Ns using the Lagrange multiplier method to enforce the
conservation
∑
s sNs = N . To do so, we minimise the following summation with λ being the Lagrange multiplier
Ftot + λ(
∑
s
sNs −N) (8)
with respect to the set {Ns}, which leads to
N1 =
V
Λ3
eλ, (9)
Ns =
V
Λ3
e(χ+λ)s+ξ for s > 1, (10)
or for s > 1,
Ns
V
= K
(
N1
V
1
m∗F
)s
, (11)
where
m∗F =
β3/2A1/2B
l20pi
1/2eβE
, (12)
K =
4pi1/2β5/2A1/2B2
l20e
βE
. (13)
(11) expresses the s-mer concentration ns ≡ Ns/V in terms of monomer concentration m = n1 ≡ N1/V . Since s can
be as big as we want, by the conservation of mass (
∑
s≥1 sns = N/V ≡ mtot), we know that m can never exceed
m∗F for otherwise the terms in the brackets in (11) will blow up with s. Indeed, we shall see that m asymptotically
approaches m∗F as mtot increases. For this reason, we shall call m
∗
F the critical fibrilar concentration (CFC) [10, 13].
Note that although the system transition from being monomer-dominated to fibril-dominated as mtot increases, it
never goes through a phase transition in the thermodynamic sense [11] since the derivatives of the free energy are
always continuous. This is also reflected, e.g., by the lack of discontinuities in mtot (Fig. 2). In the regime where
mtot  m∗F , m ' m∗F , and (11) shows that the size distribution of polymers is exponential, with the average size
given by
√
mtot/K [10, 14–16].
Let us now try to substitute in experimentally motivated parameters to see how our model corroborate with
observation. Since we are primarily interested in protein aggregation, we take the average size l0 to be 1nm, and
8the binding energy E to be 25kBT . To estimate the spring constant A and B, we make the assumption that each
monomer within a polymeric chain has a wriggle room of around 10% of its size, i.e., lc ∼ l0/10 and θc ∼ 0.1rad.
From this we can estimate A as 100E/l20 and B as 100E. Using these parameters, we find that m
∗
F ' 9.8×10−7nm−3
or around 9.8µM. The corresponding fibrillation behaviour of this system is shown in Fig. 2.
With regard to experimental observation, the predicted exponential length distribution seems to deviate from some
experimental studies [17, 18]. Van Raaij et al. has interpreted the observed peaks as a result of the finite resolution
of the atomic force microscopy imaging and length measurement procedure [19]. Besides this explanation, it is also
known that it can take on the order of months for mature fibrils to form [20]. Therefore, the appearance of the peaks
observed may also reflect the fact that the self-assembled systems have not yet reached thermal equilibrium.
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FIG. 2: Using the parameters in the text, (A) depicts how the monomer concentration changes as monomer concentration
increases; and correspondingly for the concentration of the fibrilar species (B). (C) The size (length) distribution of the system
at mtot ' 10nm−3. The distribution is exponential but note the discontinuity at s = 1 (highlighted by the red circle). The
unit of the concentrations is nm−3.
C. How to generalize to the semi-dilute limit
In the dilute limit, mutual interactions between the solutes beyond the polymerizing interactions are ignored. What
if we now increase the concentration of the solute so that such an approximation is no longer valid. This takes us
to the semi-dilute limit. We will first discuss the simplest and ubiquitous type of interactions: volume exclusion
interactions.
91. Pure volume exclusion interactions
To take steric interactions into account, we start again with the non-interacting free energy density (see (5)):
f0 = β
−1
∫
dsn(s)
[
log n(s) + log Λ3 − χs− ξ − 1] , (14)
where we have ignored the monomeric contribution, and pass to the continuum description in s since we are primarily
interested in the fibril-dominant regime (mtot CFC). We then add to f0 the following interaction term:
fint =
∫
dsds′n(s)n(s′)B(s, s′) . (15)
In the above equation, B(s, s′) is the second virial coefficients corresponding to the steric interactions of two semi-
flexible polymers of length s and s′, and is of the form [21]:
B(s, s′) =
2pi
3
l30 +
pi(s+ s′)l30
2
+ 2ss′l30| sinφ|, (16)
where φ is the angle between the two polymers. To deal with the additional variable φ, we ask ourselves what would
happen to the system given the steric interactions. From the physics of liquid crystals [22, 23], we expect that as the
polymer concentration increases, the system can become nematic, i.e., the semi-flexible polymers will be aligned.
In other words, we anticipate that similar to liquid crystals [23], as the solute concentration increases, the system
will first go through a phase separation where the regions of the system can be partitioned into two phases, one
nematic and the other isotropic. If the concentration increases further, the system will become fully nematic. This
is indeed what is observed experimentally in, for instance, a system of fibrilising hens lysozyme [24] (Fig. 3). We
will now incorporate this expected picture into our free energy minimisation. Specifically, we will consider both free
energy densities in the isotropic and nematic phases, fI and fN respectively. For fI , we can simply add to (5) the
average over the angle that two randomly oriented semi-flexible make (since the system is isotropic) in (16), hence
fI = f0({nI(s)}) +
∫
dsds′n(s)n(s′)
[
2pi
3
l30 +
pi(s+ s′)l30
2
+ piss′l30
]
. (17)
Using again the Lagrange multiplier method to enforce protein number conservation, one finds that the distribution
nI(s) that minimises fI is exponential as before, although the mean size is now
√
mIe8ψI/3/K, where mI is the total
protein concentration and ψI is the volume fraction of proteins in the isotropic phase [25].
In the nematic phase, the picture is more complicated. Since the polymers can elongate, it was found that the
flexibility of the polymer has to be taken into account in order to stop the unrealistic lengthening of the polymers in
the nematic phase [26]. Here, we will again quote the results in [25], in which it was found that by minimising the free
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energy in the nematic phase, the length distribution is again exponential, and the mean size is now approximately√
mNe4ψI/K. Here, mN is the total protein concentration in the nematic phase. These results are in the regime
where the mean polymer length is much greater than the persistence length of the polymer.
Minimizing fI and fN separately is not the whole story since there is also the possibility of phase separation.
Namely, the volume of the system can be partitioned into isotropic and nematic regions. In the thermodynamic limit,
we usually ignore the surface energy coming from the interface separating the isotropic and nematic regions. The
minimisation is thus performed on the following free energy density:
ftot(vtot,mtot) =
vIfI(mI) + vNfN (mN )
vtot
, (18)
where vI(vN ) is the total volume of the isotropic (nematic) regions and cI(cN ) is solute concentration in the isotropic
(nematic) regions. The conservation laws are therefore vI + vN = vtot and vImI + vNmN = vtotmtot. Minimising
ftot with respect to v and m finally enables us to confirm the expectation we had from the beginning. Namely, as
solute concentration increases, regions of nematic phase appear in the system and co-exist with the isotropic phase.
The polymer length distributions in both phase remain exponential, although the average length in the nematic
is higher than that in the isotropic region [27]. As the solute concentration increases further, regions of isotropic
phase disappear and the whole system will be in the nematic phase. As mentioned, these theoretical findings are
corroborated by experimental study on self-assembling hens lysozyme [24, 28] (see Fig. 3).
FIG. 3: Glass vials (1 cm wide) with hen lysozyme fibril containing solutions imaged between crossed polars. Concentrations
are indicated in mM. The lit up regions correspond to the nematic phase. Image is taken from [24] with copyright permission.
2. With lateral interactions
We have seen how the isotropic-nematic phase transition in a system of semi-flexible polymers is typically ac-
companied by phase separation. In this section, we will show that if the polymers are mutually attractive (beyond
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the end-to-end binding that leads to the joining of the two polymers), then the tendency for phase separation is
even stronger. Specifically, using again our minimal model system shown in Fig. 1, we imagine that besides the
strong directional attractive interactions schematically depicted by the red (dark grey) patches, the beads are weakly
attractive(∼ kBT ) towards each other, i.e., the green (light grey) areas of the beads are also weakly sticky.
To appreciate conceptually how interacting polymers behave at thermal equilibrium, the Flory-Huggins theory is
a good starting point since it is conceptually simple and can be easily analysed numerically. Here, we will ignore the
rigidity of the polymers and focus solely on the effects of attractive interactions on the system’s phase behaviour.
Using the lattice model where each lattice site can be either occupied by one solvent molecule and by one monomer,
the following Flory-Huggins free energy density of mixing can be derived [29]:
fm(φ) =
1
n¯
φ lnφ+ (1− φ) ln(1− φ) + χφ(1− φ), (19)
where φ is the volume fraction of the polymers in the system and n¯ is the number of monomers in the polymer.
We note that in the above formula, all polymers are of the same length, i.e., we have ignored the disperse length
distribution here for simplicity. The parameter χ summarises the interactions of the monomers and is of the form
χ ≡ z
2kBT
[2ems − emm − ess], (20)
where emm, ess, ems are the interaction energy for the monomer-monomer, solvent-solvent, and monomer-solvent
pairs on the lattice, respectively. Here, we assume that the monomers are weakly attractive (emm ∼ −kBT ) and for
simplicity, we set ess = 0 = ems. Moreover z is the coordination number of the lattice, which for a 3D cubic lattice is
6. As a result, the interaction parameter χ is −3emm/kBT .
The first two terms in (19) promotes phase separation, while for positive χ, fm becomes concave down when χ is
large enough, this is a signature of phase separation, which means that we will need to minimise the total free energy
by considering the possibility of having the system partition into two parts of distinct phases as in the previous section
(see (18)). A typical phase diagram is shown in Fig. 4.
The key feature here is that as the polymers elongate, the tendency to phase separate gets stronger even if the
polymers are only weakly attractive towards each other. Experimentally, it is observed that many amyloid fibrils
aggregate in solution and thus in-vitro and in-vivo phase separation of amyloid fibrils may be expected to occur.
Indeed, the observed clustering of sup35 fibrils in the cytoplasm of yeast cells may be a signature of such phase
separation (Fig. 5).
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FIG. 4: A typical phase diagram of a phase separating polymeric system according to the classic Flory-Huggins theory [30].
Phase separated polymer drops (inset) form in the two-phase region is bounded by the blue (dark grey) curve. At fixed peptide
volume fraction, the tendency for the system to phase separate increases as the self-assembled fibrils elongate (indicated by the
red (light grey) arrow).
D. How to incorporate oligomers
We have so far focused on the behaviour of fibrilising system in which there are only monomers or fibrils. In the
case of amyloid fibrils, the situation is more complex. Indeed, mounting evidence has indicated that proteins in the
monomeric form and oligomeric form (potentially amorphous aggregates of tens of proteins), instead of proteins in
the fibrillar form, are predominantly responsible for cell death [32]. In this section, we will incorporate the oligomeric
species into our analysis. To model the presence of oligomers, we borrow the treatment of spherical micelles formation
in a solution of surfactants [13]. Specifically, we assume that the monomers can aggregate together to form an
amorphous cluster. However, there is an optimal number of monomers, W , in the cluster in the sense that the
corresponding cluster partition function is greatest. In this system, a monomer can be classified into three categories:
(1) monomeric, (2) part of an oligomer (which we call a micelle), and (3) part of an fibril. The total partition function
in this system can be written as [10]:
Ztot =
′∏
s,p
V N1
Λ3N1N1!
(V z
(f)
s )Ns
Λ3NsNs!
(V z
(m)
p )Mp
Λ3MpMp!
, (21)
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FIG. 5: (A) Section through a tomogram of a yeast cell in which amyloid fibrils formed from Sup35 are close to the cell
membrane. The nucleus is outlined in magenta and the vacuole in brown. (B) Rendered 3D model from serial tomograms
of this cell. Amyloid fibrils are in green; membrane, blue; nucleus, magenta; vacuole, brown; mitochondria, purple; and large
complexes (presumably ribosomes) as gray dots. (C) Section through of a cell in which the aggregate of amyloid fibrils is of
a form of a drop (green). (D) Rendered 3D model of the dot from serial tomograms. (Coloring as in B.) This figure is taken
from [31] with copyright permission.
where z
(f)
s and z
(m)
p are the internal partition functions for the fibrillar and micellar species. We have also singled out
the monomeric contribution to the partition to highlight the fact that there are three different species in the system.
We now model the micellar partition function as
z(m)p = δpW
( α
Λ3
)W−1
eWEm , (22)
where α is of the order of the dimension of the monomer. Specifically, all micelles are assumed to be of size W for
simplicity and the clustering is driven by the binding energy Em per monomer. If we ignore the fibrillar species for the
time being, then using again the Lagrange multiplier method as before, we find that we can again relate the micellar
concentration to the monomer concentration m:
mW =
1
α
(
m
m∗M
)W
, (23)
where m∗M = (αe
βEm)−1. For W ∼ O(10), we can see that m is bounded above at around m∗M , i.e., most monomers
are in the micellar form at mtot > m
∗
M . On the other hand, for m m∗M , mK is negligible. For this reason, we call
m∗M the critical micellar concentration (CMC).
If we now incorporate the fibrilar species into the picture, the system is effectively partitioned into multiple regimes:
if mtot is smaller than both the CMC and the CFC, then the system is dominated by mtot. If the CMC is lower than
the CFC and mtot > CMC, then the micellar species will dominate the system; while if the CFC is lower than the
CMC, fibrils will be dominant if mtot > CFC [10] (Fig. 6A). Note that even though if the CFC is lower than the CMC,
14
the micelles would still be transiently present in the system, and their existence may have important implications in
the fibrillation kinetics as proposed in [33] (Fig. 6B). A similar model has also been recently studied using molecular
dynamics simulation in [34].
FIG. 6: (A) At fixed mtot, the system can be dominated by distinct species depending on the strength of the fibrilar binding
energy EF and the micellar binding energy EM . (B) A schematic of a potential nucleation pathway of fibrillation proposed in
[33]. Starting with a pool of monomers, micelles form quickly due to the fast (potentially diffusion-limited) formation kinetics.
within the micelles, the protein concentration is high and thus facilitates the slow nucleation of nuclei of fibrils. As fibrils
elongate, the monomers in the system will be eventually depleted below the CMC and thus the micelles will disappear in the
system.
E. How to incorporate internal monomeric structures
Another natural generalisation of our minimal bead-and-stick model is the incorporation of the internal monomeric
structure into our analysis. A peptide can in general be in multiple states, e.g., in the form of a beta sheet, random
coil, alpha helix. In the specific case of Aβ peptides, the monomeric state is in the random-coil configuration, while
the peptides are predominately in the beta-sheet state in the fibrillar form [35]. In terms of our minimal model, we
can account for this modification by assigning a nonzero value to the monomeric partition function z
(R)
1 = γ > 0
corresponding to the random coil state in (2); while for monomers in the beta-sheet form, the monomeric partition
function z
(β)
1 is again set to one. Here, γ is positive means that the monomer in the random coil state is preferred
over the beta sheet state in the fibrillar form, which originates from the fact that the random coil is entropically
more favourable. At thermal equilibrium, we expected have m(β) = e−γm(R). The total monomer concentration
m is therefore m(β) + m(R) = m(R)(1 + e−γ). Incorporating the fibrillar species into the picture and writing the
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concentration of s-mers in terms of that of the monomer as done in (11), we have
ns = K
(
m(R)
eγm∗F
)s
= K
(
m
mˆ∗F
)s
(24)
where mˆ∗F is (1+e
γ)m∗F (see (11)). In other words, most of qualitative analyses as before remains the same, except now
the critical fibrillar concentration is increased by the factor (1 + eγ), which signifies that the monomeric concentration
m is generally increased when the random coil-beta sheet transition [36, 37] is taken into account at the monomeric
level. We note that a more detailed analysis of the effects of the degree of freedom from the monomeric conformation
can be found in [3].
F. How to incorporate multiple fibril morphologies
Besides the possibility of micelle formation, real biopolymers, and amyloid fibrils in particular, are likely to consist
of two or more filaments. In addition, multiple morphologies may co-exist in the system [38]. The simplest way to
model such a system is to imagine that each bead in Fig. 1A also possesses a sticky patch on the equator. If the new
“patch on the side” is small in area, then a two-filament fibril will form naturally (Fig. 7). In fact, many amyloid fibrils
seemed to consist of filaments twisted together, which could be incorporated into our minimal model by twisting the
location of the side patch along the axial direction (Fig. 7). The formalism employed so far can again be generalised
to consider this system. Interestingly, as far as minimising the total free energy is concerned, the only effects of the
lateral association of filaments are to double the capping energy E, where the factor 2 comes from the additional
axial bond due to the bundling of the two filaments [27]. Because of this increase of capping energy via bundling, the
species that dominate the system will always be the two-filament polymers. So how does this theoretical predictions
square with experimental observations that multiple morphology exist? The simplest resolution again points to the
conclusion that under typical experimental conditions, the self-assembly of amyloid fibril has not yet reached the
thermal equilibrium state.
G. Summary
Here we will summarise the key conclusions one can draw from statistical mechanics with regards to biopolymer
self-assembly.
1. The existence of a critical fibrillar concentration (CFC) below which fibrillar mass is negligible. The emergence
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FIG. 7: A schematic of a twisting fibre consisting of two filaments. In this model, besides the axial bonds (blue arrows) along
the longitudinal direction of the fibre, there are lateral bonds (red patched) that bind the two filaments together.
of such a critical concentration comes purely from the fact that the aggregates concerned consist of a large
number of monomers.
2. Above the CFC, the length distribution of the fibrils is exponential. This remains so even in the semi-dilute
limit if the fibril-fibril interactions are purely steric.
3. When micellar or other oligomeric species are taken into account, each distinct type of aggregates will have their
specific critical concentrations, and the one with the lowest critical concentration will have the dominating mass
density at high protein concentration (Fig. 6).
4. If fibrils of distinct widths exist, the mass density of the widest fibrils will dominate the system at thermal
equilibrium.
5. If the fibrils exhibit attractive lateral interactions, there will be a strong tendency for phase separation of fibrils
to occur.
We note that the existence of CFC is a well established experimental observation. However, experimentally measured
fibrillar length distributions seem generally to deviate from the predicted exponential distribution. In addition,
multiple morphologies of fibrils seem to co-exist in typical experimental conditions. These observations indicate that
protein amyloid formation does not reach thermal equilibrium at the typical experimental timescale. Therefore, to
account quantitatively for the experimental observation, we generally need a kinetic description of amyloid fibrillisation
tailored for the specific experimental condition.
III. KINETICS OF AMYLOID FIBRILLATION
In the first part, we have presented a general review on the thermodynamics of amyloid fibrillation. However, due
to the lack of a mature non-equilibrium thermodynamics theory, currently we can only deal with the equilibrium
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states and the phase transition between them. In order to understand many unsolved puzzles concerning with the
time evolution of an amyloid system, such as how fibrils grow, how they replicate, how they interact with cells and be
cytotoxic, we need to turn to a kinetic theory. The mathematical modeling based on chemical mass-action equations
provides us a unified framework as well as a quantitative linkage between experimental observations and underlying
molecular mechanisms. Fruitful results and interesting physical insights have been obtained based on this formulation
in the past several years. In what follows, we will focus on two aspects: one is a systematic exploration of the kinetic
formulation of amyloid fibrillation, including both molecular mechanism basis and model analysis (Fig. 8); the other
is the mathematical foundation of kinetic modeling as well as its linkage with experimental facts.
A. How fibrils grow
When examining a given amyloid system, a first question coming to mind usually would be how amyloid fibrils are
able to grow? Regardless of various possible explanations for other self-assembling phenomena in nature [39–42], we
are really astonished at the fact that there is one truly simple answer valid for almost all amyloid fibrils. That is
elongation, the process of which incorporates free protein molecules (or monomers as stated in literature) into existing
fibrillar aggregates by monomer association and dissociation at fibril ends in a linear sequential way. Elongation not
only is a geometrical consequence of the intrinsic one-dimensional structure of amyloid fiber, but also has a deep root
in both thermodynamics and kinetics, that is monomer association is more favorable than that of oligomers in general
[43, 44]. We will come back to this point later.
As an elementary step in amyloid fibrillation, elongation has been paid great attention to in the past studies.
Pioneer works dated back to Oosawa and his colleagues for their preliminary examination on actin formation in the
late 1950s [45]. They are among the first ones who wrote down the explicit reaction schemes and rate laws for protein
self-assembling, i.e. once formed by nucleation processes (which will be discussed in next section), actins will extend
or shrink by association or dissociation of monomeric units at one end mostly. They further verified that the initial
rate of actin growth varies linearly with the monomer concentration, which implies that monomeric, rather than
oligomeric, subunits have been added to actin filaments and make them to grow [43], since the latter will give rise to
a nonlinear dependence on the monomer concentration.
The linear dependence of elongation rate on the monomer concentration has been further investigated by Collins
et al. through a combination of kinetic modeling and single-molecule fluorescence measurements on the NM domain
of yeast prion protein Sup35 [44]. Again, the initial rate of fiber growth was found to be directly proportional to the
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FIG. 8: A cartoon depicting various microscopic mechanisms of amyloid fibrillation discussed in the current paper.
concentration of soluble NM over a range of 0 ∼ 1µM . However, at a higher NM concentration (> 10µM), the rate of
fiber growth shows a weaker-than-linear law. The reason for this is believed to be “a conformational rearrangement of
NM after binding to fiber ends becomes rate limiting at high NM concentration” [44], a specific case of the saturation
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phenomenon. A quantitative treatment will be presented in the section of saturation.
Recently, Knowles and his colleagues developed a novel technique to measure the rate of fiber elongation directly
[46, 47], which to some extent avoids the indistinguishability of several different fibrillation processes presented simul-
taneously in traditional methods. According to their setup, prepared fragments of amyloid fibrils have been attached
to the surface of a quartz transducer. So that, once new monomers add to the fibrils, the resulting nanogram mass
changes will be monitored through a shift in the resonance frequency of the quartz oscillator. Again, two different
regimes in the fiber elongation rate are highlighted: an initial linear dependence on the monomer concentration, and
a subsequent saturation of the growth rate at high monomer concentrations.
In literature, the possibility of fiber elongation through oligomer addition has been discussed from time to time [48–
51]. For example, Serio et al. proposed a oligomer-based mechanism called “Nucleated Conformational Conversion”
[48], in which “structurally fluid oligomeric complexes appear to be crucial intermediates in de novo amyloid nucleus
formation” and “rapid assembly ensues when these complexes conformationally convert upon association with nuclei”,
to explain the assembling of prion protein Sup35. However, since in general “monomer addition is more rapid and
efficient” than oligomer addition [44], nowadays a common conclusion has been reached that fiber elongation has
a first-order concentration dependence on both monomeric and fibril species, revealing a bimolecular mechanism of
growth through monomer addition to both ends of existing fibrils.
Now we are going to formulate above discussions into a quantitative model. If only the elongation process is
included, it is straightforward to show that the mass concentration and number concentration of aggregates (see their
mathematical definitions and physical meanings in section of how to quantify fibrillation kinetics) evolve according to
following equations:
d
dt
P = 0, (25)
d
dt
M = k+e mP − k−e P, (26)
where k+e and k
−
e denote the reaction rate constants for monomer association and dissociation respectively. Clearly,
the first term on the right-hand side of (26) represents the desired process of fiber elongation by monomer addition
at fibril ends (here the geometrical factor 2 is not directly written out); while the second one is the corresponding
inverse process, whose necessity lies on “the maintenance of monomer pool” in the equilibrium state [52].
It is noted that, according to (25), the number concentration is conserved, i.e. P (t) = P (0). This is a significant
feature of elongation, in contrast to all kinds of nucleation processes which will be introduced in the following section.
Towards the mass concentration, obviously its growth rate is maximal at the beginning of the reaction and then
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decreases monotonically. Actually, we have
M(t) = (M0 − )e−κt + , (27)
where κ = k+e P0,  = mtot − k−e /k+e , M(0) = M0 and P (0) = P0 are the initial mass and number concentrations
of aggregates. Accordingly, the half-time and apparent fiber growth rate (see section on how to quantify fibrillation
kinetics for their definitions) are given by
t1/2 =
ln 2
κ
∝ P−10 , (28)
kapp =
+M0
2mtot
κ ∝ P0. (29)
Here, both t1/2 and kapp are only concerned with the number concentration of seeds P0 rather than the mass con-
centration M0. This is another significant feature of the elongation process. Contrarily, as we will show, the speed
of secondary nucleation generally depends on the mass concentration of seeds M0; while that of primary nucleation
does not rely on seeds at all. Finally, from the static solution M(∞) = , we can exactly see that the inverse reac-
tion – monomer dissociation is essential to maintain a genuine thermodynamic equilibrium as well as an observable
“monomer pool” at the end of reaction [52].
In (26), the rate constants for monomer association and dissociation are assumed to be independent of fibril length.
An indirect support comes from the argument that they are “characterized by the local interaction of a monomer
with the end of a fibril”, so that “the total length of the fibril is likely to introduce only a minor effect through
the reduction of the diffusive encounter rate when the size of the fibril increases” [47]. Under the assumption of
fibril length independence, there are plenty of studies attempting to determine exact values of the rate constants for
monomer association and dissociation. For example, by AFM analysis Collins et al. reported the rate constant for
fiber elongation of yeast prion protein Sup35 is approximately k+e ≈ 2 × 105M−1s−1 at a soluble NM concentration
of 2.5µM and can be two times bigger at higher concentrations [44]. Knowles et al. found an elongation rate of
(9.2± 0.3)× 103M−1s−1 for insulin at a concentration of 0.17mM by quartz crystal microbalance, equivalent to one
molecule attaching every 3.1±1.2s on average [46, 53]. At 2.5mg/ml Aβ25−35 peptide, Kellermayer et al. determined
k+e ≈ 106M−1s−1 and k−e ≈ 10s−1 through scanning-force kymograph, given the equilibrium monomer concentration
to be 10µM [54]. In a similar way, referring to a critical concentration of α-synuclein at 2µM , Pinotsi et al. [55] gave
an average growth rate of k+e ≈ (1 ± 0.375) × 103M−1s−1 as well as a lower bound for the average dissociation rate
k−e ≈ (2.0± 0.8)× 10−3s−1 by two-color single-molecule localization microscopy.
From above far-from-complete list, we can clearly see that the rate constant for fiber elongation varies for at least
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three orders of magnitude from protein to protein and could also be influenced by the pH condition, salt concentration,
temperature and etc. [55]. This fact to some extent reveals the intrinsic high complexity and heterogeneity of fiber
elongation processes. Actually, for the growth of individual filament, an intermittent, stop-and-go behavior has been
widely confirmed [56, 57], which shows fiber elongation operates “in a way analogous to the landscape models of
protein folding defined by stochastic dynamics on a characteristic energy surface” [27, 47]. Therefore, the current
single-reaction-rate-based picture turns out to be a rough average of various underlying stochastic processes concerning
with the fiber growth. Readers should be aware of this point.
B. How fibrils replicate
Generally speaking, the fibrillation of amyloid proteins is constituted by two aspects: nucleation and growth. In
the previous section, we have shown how elongation provides a simple way to let fibrils grow. But we still lack a
knowledge on where those templates (or seeds) for elongation come from and how they evolve during the fibrillation
procedure. As far as we know, there are at least three basic processes contributing to the generation of new seeds, i.e.
primary nucleation, surface-catalysed secondary nucleation and fragmentation. There is a long story for the study of
primary nucleation in crystal and liquid formation. Surface-catalysed secondary nucleation and fragmentation present
two alternative ways to bypass the slow seeding procedure of primary nucleation by making use of existing fibrils in
the system, so they are also named as “secondary nucleation” in literature. A major difference between them is that
the former dependents on the monomer concentration, while the latter does not.
Secondary nucleation plays a key role in the fibrillation of amyloid proteins [6, 58]. In the presence of secondary
nucleation, the fibrillation speed will be dramatically accelerated and time courses for fiber mass concentration will be
changed into a sigmoidal shape with prominent lag phase. Furthermore, in contrast to primary nucleation and surface-
catalysed secondary nucleation, fragmentation will not only cause a global change of the fiber length distribution, but
also largely enhance the cytotoxicity by generating more harmful oligomers. Detailed discussions could be found in
following sections correspondingly.
1. Primary nucleation: rate-limiting step
For different amyloid proteins under different conditions, time courses for fibrillation may vary considerably from
each other, but in general a sigmoidal-like behavior with a prominent lag phase is observed if initial proteins are all in
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monomeric form [59]. Furthermore, by introducing certain amount of pre-seeded filaments into the system at the very
beginning of the reaction, the lag phase can be completely removed [5]. This evidence reveals that amyloid fibrillation
involves a process called primary nucleation, in which nuclei of aggregates are formed from monomeric proteins directly.
In contrast, the formation of amorphous aggregates, which often acts as competitive pathways against regular amyloid
fibrils, is generally believed to follow a non-nucleated polymerization (or random polymerization) [60–62].
The idea of primary nucleation has been extensively explored in various natural phenomena, such as the formation
of snow flakes, clouds and bubbles, the crystallization of mineral, metal, protein and DNA, etc. [63–69]. It is the
first step in the formation of either a new thermodynamic phase or a new structure via self-assembly, and typically
determines how long we have to wait before the new phase or self-organised structure appears. According to whether
the process is catalyzed by particles of foreign substance (like surface and substrate) or not, primary nucleation could
be further divided into two categories: homogeneous nucleation and heterogeneous nucleation. The latter usually
occurs much more often and faster than the former. This behavior could be understood by classical nucleation theory
(CNT), which predicts the nucleation rate [70–72]
R = NSZje
(−∆G∗
kBT
)
, (30)
where ∆G∗ is the free energy barrier for forming a critical nucleus, which will be explicitly defined later. kBT
represents the thermal energy with the Boltzmann constant kB and the absolute temperature T . NS is the number
of nucleation sites. j is the rate for monomers attaching to the nucleus. Z is called the Zeldovich factor, which is the
forward probability for a critical nucleus to grow diffusively into a larger nucleus rather than shrink back to nothing.
To further model the free energy barrier, CNT treats the microscopic nucleus as a macroscopic droplet, so that the
free energy ∆G for forming a nucleus can be generally written as the sum of a bulk term proportional to the volume
of the nucleus and a surface term proportional to its surface area. Especially for homogeneous nucleation, the nucleus
modeled by a sphere of radius r gives [70–72]
∆G =
4
3
pir3∆g + 4pir2σ. (31)
The first term stands for the volume contribution, in which ∆g is the free energy difference per unit volume between
the nucleated and non-nucleated phases and usually negative. The second term comes from the interface between the
nucleus and its surroundings. σ is the surface tension and always positive. As a consequence, for small r, the surface
term dominates and ∆G(r) > 0; while for large r, the volume term dominates and ∆G(r) < 0. Especially at some
intermediate value of r, the free energy goes through a maximum, corresponding to a least probability for nucleus
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occurring. This is called the critical nucleus and occurs at dG/dr = 0, which gives a critical nucleus radius
r∗ = − 2σ
∆g
. (32)
Adding new monomers to nuclei larger than this critical radius decreases the free energy, so the overall nucleation rate
is then limited by the probability of forming the critical nucleus, which is ∆G∗ = 16piσ3/[3(∆g)2]. This is exactly the
free energy barrier needed in the CNT expression for the nucleation rate R above.
The reason for heterogeneous nucleation occurring much easier than homogeneous nucleation is that the nucleation
barrier ∆G∗ is much lower at a surface. For homogeneous nucleation, the nucleus is approximated by a sphere.
However, for heterogeneous nucleation, when a nucleus is formed at the surface, its form is not completely spherical
and depends on the contact angle [73, 74]. This geometrical factor reduces the interfacial area and so the interfacial
free energy, which in turn reduces the nucleation barrier. In principle, we expect nucleation to be fastest when the
nucleus forms a small contact angle on its surface. However, detailed calculation is not straightforward and will not
be listed here.
From the kinetic aspect, primary nucleation, including both both homogeneous and heterogeneous nucleation, is
often modelled with the following formula [33, 75]
dP
dt
= kn(m−m∗F )nc , (33)
where kn is the macroscopic reaction rate constant. With respect to the microscopic nucleation rate R considered
in above thermodynamic picture, we expect limV→∞R/Ns = kn in the limit of sufficiently large volume. m∗F is the
critical fibrillar concentration and (m−m∗F ) is also known as supersaturation. Supersaturation is the driving force for
both the initial nucleation step and the following growth, both of which could not occur in saturated or undersaturated
conditions. nc stands for the critical nucleus size, that can be as large as 10, but generally ranges between 2 and 4.
In the 1960s, Oosawa et al. borrowed this idea to study of the polymerisation of actin [43, 76] and wrote down
a reaction scheme consisting of three basic process – primary nucleation, monomer association and dissociation.
However, they did not include the supersaturation effect explicitly, since mostly the protein concentration used for
fibrillation is much higher than that required for saturation. According to Oosawa’s model, the number concentration
and mass concentration of aggregates evolve according to
d
dt
P = knm
nc , (34)
d
dt
M = k+e mP−k−e P + ncknmnc . (35)
24
In above model, the inverse process for primary nucleation has been omitted. A major reason is that it is accounted
by a boundary term k−n [Anc ] (where k
−
n is the rate constant and [Anc ] is the concentration of critical nucleus), not
compatible with other terms constituted by moments M and P (the moment-closure method we introduced in the
section of how to coarse-grain model can systematically solve this problem). The last two terms underlying in (35) are
generally negligible too, due to the fact that under proper fibrillation conditions, fiber elongation is more energetically
favorable and proceeds faster than primary nucleation and monomer dissociation [43]. This leads to an important
conclusion – the major role of primary nucleation in fibrillation is to generate new seeds rather than directly consuming
free monomers like elongation. Similar argument also applies to secondary nucleation introduced in the next section.
Typical amyloid systems, which follow above mechanism without referring to secondary nucleation, include actins in
KCl solvents [77] (see Fig. 9A), γC-crystallin [78] and Apo C-II [79] etc.
According to [80], Oosawa’s model admits analytical solutions as follows
M(t) = mtot − (mtot −M0)
[
µsech
(
ν + λβµt
)]2/nc
, (36)
P (t) = P0 + kn(mtot −M0)ncµ(βλ)−1
[
tanh(ν + βλµt)− tanh(ν)], (37)
where λ =
√
knk
+
e (mtot −M0)nc , β =
√
nc/2, γ = βk
+
e P0/λ, µ =
√
1 + γ2 and ν = arcsinh(γ). mtot, M(0) = M0
and P (0) = P0 are the total protein concentration, initial mass and number concentrations of aggregates respectively.
Especially, in the absence of initial seeds M0 = P0 = 0, we have M(t) = mtot[1 − sech2/nc(λβt)], which recovers the
classical Oosawa’s result [76].
Insight into the early time behaviour of fiber mass concentration can be obtained by expanding (36) around t = 0
M(t) = M0 + k
+
e P0(mtot −M0)t+
1
2
(mtot −M0)[λ2 − (k+e P0)2]t2 +O(t3), t→ 0. (38)
This expression recovers the characteristic t2 dependence relating to the primary nucleation in Oosawa’s theory [76].
An additional term linear in time is raised by the growth of pre-added seeds. This difference actually provides a
simple way to distinguish the seeding contributions from primary nucleation and pre-added seeds.
After some calculation, the half-time and the apparent fiber growth rate are given respectively as
t1/2 =
1
λβµ
[
arccosh(2nc/2µ)− ν], (39)
kapp =
λβµ
nc
mtot +M0
mtot
√
2ncµ2 − 1. (40)
According to above integrated rate laws, we can easily see that, in the absence of initial seeds M0 = P0 = 0, the
half time of fibrillation is proportional to λ−1, which means t1/2 ∝ m−nc/2tot , a prominent feature of seeding through
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primary nucleation; on the contrary, if high concentrations of preformed seeds are added to the system, γ  1 and
we recover results for pure elongation t1/2 ∝ (k+e P0)−1.
Again, we can take advantage of this difference in scaling relations to separate the elongation process from primary
nucleation. At first, without any initial seeds, the critical nucleus size for primary nucleation nc could be directly read
out by examining the scaling dependence of half-time under different initial monomer concentrations. Furthermore,
parameter λ provides a combined knowledge of both primary nucleation and elongation. Finally, by adding high
concentrations of performed seeds into the system, seeding through primary nucleation will be completely suppressed
and the elongation rate could be extracted from the fibrillation kinetics solely. Similar argument is also applicable to
secondary nucleation.
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FIG. 9: Actin growth in the presence of KCl v.s. MgCl2, which highlights two different dominated mechanisms [81]. (A)
Action samples were prepared with 40 mM KCl at monomer concentrations mtot = 7.4, 9.6, 12.4, 14.2, 16.2, 18.4, and 20.5 µM
separately (blue circles). Predictions based on the NE model (red dashed lines) in (34) and (35) were performed with nc = 4,
kn = 3×109M−3s−1, k+e = 9×102M−1s−1, k−e = 10−3s−1. (B) Action samples were prepared with 0.6 mM MgCl2 and 0.5 mM
EGTA at monomer concentrations mtot = 6.7, 8.5, 11.5, 14.9, 17.3, 20.3, and 22.9 µM. Predictions based on the NEF model
in (47) and (48) were performed with nc = 6, kn = 2× 1016M−5s−1, k+e = 9× 104M−1s−1, k−e = 0.18s−1, k+f = 6× 10−7s−1,
k−f = 0.
2. Monomer-dependent secondary nucleation: self-catalysed process
As indicated by the early time expansion of solutions for primary nucleation, a linear growth in the presence of
initial seeds and a growth depending on t2 for purely monomeric proteins are expected [82], which cannot account
for the apparent high cooperativity of fibrillation observed in many amyloid systems. For example, in 1980 Ferrone
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et al. [83] observed an exponential growth at the early stage of aggregation for the aberrant gelation of sickle-
hemoglobin. Later, they studied the kinetics of polymerization of hemoglobin S and found a transition time much
shorter than the lag phase predicted by primary nucleation only [84, 85]. Miranker et al. observed a similar process
in Islet amyloid polypeptide (IAPP) [86]. Intriguingly, they found that both the reaction order and the activation
enthalpy of two nucleation processes are identical, which made them to conclude that both primary nucleation and
monomer-dependent secondary nucleation are “alternative manifestations of the same, surface-catalyzed nucleation
event” [87]. Above observations confirmed the existence of a secondary pathway for nucleation, which generates new
nuclei by making use of the surface of existing aggregates in the system. Therefore, this kind of mechanism is called
surface-catalysed secondary nucleation. Since it depends on both monomer concentration and fiber concentration, it
is also known as monomer-dependent secondary nucleation, in contrast to a different kind of secondary nucleation
mechanism – fragmentation that is monomer independent. Just as Miranker claimed, monomer-dependent secondary
nucleation is a special kind of heterogeneous nucleation and takes the surface of amyloid fibrils as catalyst. Therefore,
it proceeds much faster than primary nucleation and exhibits an exponential growth due to the self-catalysed nature.
Besides sickle-hemoglobin[83], hemoglobin S [84, 85] and IAPP [87], Aβ40 [88] and Aβ42 [89, 90] (See Fig. 10) have
also been revealed to adopt the surface-catalyzed secondary nucleation mechanism.
A model, incorporating both primary nucleation and monomer-dependent secondary nucleation, could be expressed
as
d
dt
P = knm
nc + k2m
n2M, (41)
d
dt
M = k+e mP − k−e P+ncknmnc + n2k2mn2M, (42)
where the new term k2m
n2M accounts for the contribution of secondary nucleation on seeding, which is proportional
to the surface area of existing aggregates (scale as M). The parameter n2 stands for the critical nucleus size for
secondary nucleation, analogous to nc for primary nucleation. It is noted that when n2 = 0, above equations offers a
good approximation to the model of fragmentation, an alternative secondary nucleation mechanism going to be shown
in the next section. Therefore, we can use the same model to describe both monomer dependent and independent
secondary nucleations by just tuning the parameter n2. As we have stated in the section of primary nucleation that
the major role of various nucleation processes is to create new sites for elongation rather than increasing the mass of
aggregates directly, the terms underlying in (42) could be neglected with respect to elongation.
Under this condition, first-order self-iterative solutions have been obtained through fixed-point analysis [91] by
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Cohen et al. [92] as
M(t) = M(∞)− [M(∞)−M0]e−k∞t
(
B− + C+eκt
B+ + C+eκt
· B+ + C+
B− + C+
)k2∞/(κk¯∞)
, (43)
P (t) =
Pl(t)
1 + Pl(t)/P (∞) , (44)
in which Pl(t) = (C+κe
κt + C−κe−κt)/k+e is the linearized solution for early time. κ =
√
(k+e m0 − k−e )k2mn20 ,
λ =
√
k+e knm
nc
0 , C± = k
+
e P0/(2κ) ± k+e M0/[2(m0k+e − k−e )] ± λ2/(2κ2), k∞ = k+e P (∞), k¯∞ =√
k2∞ − 4C+C−κ2, B± = (k∞ ± k¯∞)/(2κ). M(0) = M0, P (0) = P0 and M(∞) = mtot − k−e /k+e , P (∞) =
(k+e )
−1
√
2κ2/[n2(n2 + 1)] + 2λ2/nc + 2M0κ2/(ncm0) + (k
+
e P0)2 are the aggregates number concentration and mass
concentration at the beginning and in the equilibrium respectively. m(0) = m0 = mtot −M0 and mtot are the initial
and total monomer concentrations. Alternative solutions for early time based on perturbation methods could be found
in [85, 93] and we will not go into them here.
According to self-iterative solutions, the half-time and apparent fiber growth rate can be extracted,
t1/2 ≈ κ−1 ln(1/C+), (45)
kapp ≈ κ
2
k2∞/(κk¯∞)
B+ + 1
. (46)
It is clear, in the absence of initial seeds M0 = P0 = 0, the half time of fibrillation is around 2κ
−1 ln(κ/λ), which
means t1/2 ∝ m−(n2+1)/2tot , a feature of seeding through secondary nucleation. As primary nucleation only enters into
the half-time through a logarithmic correction, its influence will be limited to early time, which is expectable since
secondary nucleation is more effective in generating seeds. Furthermore, even if medium amount of preformed seeds
are introduced to the system λ k+e P0  κ, the scaling dependence of half-time on monomer concentration will not
be changed except for a logarithmic correction, showing only primary nucleation is screened out in this step. Unless
high concentrations of preformed seeds are added k+e P0  κ, we can not eliminate the effect of secondary nucleation
and recover the result for pure elongation t1/2 ∝ (k+e P0)−1.
Since the major role of primary nucleation and secondary nucleation is to generate new seeds, it is generally
expected, by introducing preformed seeded into the system, various nucleation mechanisms could be partially or even
completely screened out. The examination above confirms this point from an analytical point. In particular, we see
that firstly primary nucleation and then secondary nucleation are suppressed with an increase of seeds concentration.
As long as two nucleation processes are well separated in time, given by
√
k+e knm
nc
tot 
√
k+e k2m
n2+1
tot , rates of
primary nucleation, secondary nucleation and elongation could be extracted respectively by simply varying the seeds
concentration. In this way, the significant role of seeds in fibrillation kinetics could be fully appreciated. All these
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discussions are applicable to the fragmentation case in the next section by just setting n2 = 0.
FIG. 10: Kinetics of A42 aggregation is shifted from surface catalyzed secondary nucleation dominated mechanism to frag-
mentation dominated by continuously increasing agitating speeds. The upper plots show the time profile of A42 aggregation
under different shear rates generated by agitating the sample under different speeds; and the lower ones show the corre-
sponding power-law relationships between the half-time and the initial monomer concentration of A42. In (A), the rate
parameters
√
k+e kn = 42.4M
−1s−1 and
√
k+e k2 = 2.8 × 105M−3/2s−1, nc = n2 = 2 are fixed and k+f = k−f = 0. In (B)-(F),√
k+e k
+
f = 0.6, 0.9, 1.4, 1.9M
−1/2s−1 are taken respectively under each shear rate in replace of
√
k+e k2. Figure is taken from
[90] with copyright permission.
3. Monomer-independent secondary nucleation: fragmentation and annealing
Another efficient way to generate seeds without involving primary nucleation is fragmentation, which means one
filament breaks into two smaller fragments. In principle, breaking into three or more pieces simultaneously is also
possible but extremely rare. The universality of fragmentation in amyloid formation has long been established in the
famous book of Oosawa [43]. It is well-known that single filament becomes mechanically unstable and tends to break
when exceeding certain threshold in length [44, 58]. Even for bundled fibrils, breakage is unavoidable in the presence
of mechanical stress [94], thermal motion [95–97], or chaperons like Hsp104 [98].
Compared to surface-catalysed secondary nucleation, fragmentation is monomer-independent and thus becomes
predominant under the condition of low monomer concentration. It can dramatically accelerate the formation of
breakable filaments and change time courses for mass concentration of aggregates into a sigmoidal like behavior.
Fragmentation could further alter the fiber length distribution globally just like elongation and enhance the toxicity
of fibril samples by generating more harmful oligomers in low molecular weight. Due to its significant roles in both
amyloid fibrillation and cytotoxicity, fragmentation has been paid plenty of attention to in past studies. And many
typical amyloid systems have been shown to follow this mechanism, including actins in MgCl2 solvents [77] (see Fig.
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9B), Sup35 NW region [44], Ure2p [99], CsgBtrunc [100], Stefin B [101], β2-microglobulin [102], WW domain [103],
α-synucleins [104] and insulin [105] etc.
Generally speaking, fragmentation rates are length-dependent. In literature, several assumptions have been pro-
posed, including the random scission, the central scission, and the Gaussian scission [106, 107] and modified par-
tially random scission [108] etc. The latter two got supports from fiberlike PI264-b-PFS48 micelles under sonica-
tion [109], thermodynamically induced shear degradation of polystyrene in semiconcentrated solutions [107], single-
stranded random-coiled poly-(uridylic acid), double-stranded helical DNA, and triple-stranded helical poly-(adenylic
acid)·2poly(inosinic acid) [108]. Hill suggested a formula in log form for polymer fragmentation and annealing based
on statistical mechanics [110]. And it has been applied by Hong et al. to the study of several amyloid proteins [111].
In the presence of fiber-length-dependent fragmentation, the derivation of self-closed models for fiber formation
becomes a big trouble. Based on Maximum Entropy Principle [112–114], a systematical and reliable way has been
proposed to derive close-formed mass-action equations from microscopic length-dependent fragmentation models [111]
(see section on how to coarse-grain model for details). In particular, under the assumption of totally random scission
(or length-independent fragmentation), the kinetics of fiber formation can be expressed by the following model:
d
dt
P = knm
nc + k+f [M − (2nc − 1)P ]− k−f P 2, (47)
d
dt
M = k+e mP − k−e P+ncknmnc , (48)
where k+f is the rate constant for length-independent fragmentation, and k
−
f is that for the inverse process – filaments
annealing. Terms for fiber fragmentation and annealing in (47) are explicit and can be obtained directly from the
microscopic model. Since here fibrils are not allowed to break into monomers directly and so is annealing, no term for
fragmentation or annealing will enter into the equation for M(t). This is a dramatic feature of fiber fragmentation
and annealing, which only affect the number concentration of aggregates and keep the mass concentration conserved.
As an inverse process of fragmentation, filaments annealing is crucial for the fiber length distribution, number
concentration of aggregates as well as their average length. Based on (47), it is clearly seen that in the absence of
annealing (by setting k−f = 0), the average length of fibrils will be around 2nc − 1, in contrast to the estimated lower
bounds of at least hundreds of monomers.
Again, by fixed-point analysis, self-iterative solutions could be derived in exactly the same form as those in (43) and
(44), except for some internal parameters have to be changed correspondingly [115], i.e. the linearized solution for early
time Pl(t) = C1e
k1t + C2e
k2t − nck+f , number concentration of aggregates in equilibrium P (∞) = 2M(∞)
(
2nc −
1 +
√
(2nc − 1)2 + 4k−f M0/k+f
)−1
, κ =
√
(k+e m0 − k−e )k+f , as well as C± = k+e C1,2/k1,2, where k1,2 = −k−f P0 ±
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(k−f P0)2 + κ2, C1,2 = (1 − k2,1/k1,2)−1[P0 − k2,1(M0 + knmnc0 /κ2 + nck+f k−f P0/κ2)]. The same expressions for
the half-time and apparent fiber growth rate could be obtained as in (45) and (46) and will not be addressed here.
Just note in current case, except for a logarithmic correction, t1/2 ∝ m−1/2tot and kapp ∝ m1/2tot , a special case of
monomer-dependent secondary nucleation with n2 = 0 for fragmentation as we claimed.
Models constituted by above four basic mechanisms: elongation, primary nucleation, surface-catalyzed secondary
nucleation and fragmentation (as well as monomer dissociation and filaments annealing as two typical inverse pro-
cesses) could already explain most fibrillation kinetics observed in experiments. In the past several years, fruitful
results have been obtained in this direction [5, 6], which greatly enhance our understandings on the underlying mi-
croscopic processes, the kinetics and thermodynamics of amyloid fibrillation, effects of pH value, temperature and
etc. Besides this main framework, several key issues need to be addressed to provide a complete picture. Firstly, we
have mentioned that high monomer concentration could dramatically change the kinetics of amyloid formation, which
is known as saturation. Luckily, the effect of saturation could be easily accounted through a Michaels-Menton-like
formula, though model analysis becomes far more difficult. Secondly, it is well-known that the formation of amyloid
fibrils is a direct consequence of protein misfolding, and the conformational conversion of monomers and oligomers
plays an inreplaceable role in it. However, the step of conformational conversion is easily neglected in kinetics due to
the interference of primary nucleation.
C. How high concentration affect
In the section of fiber growth, we have mentioned that fiber elongation shows a sub-linear dependence in the
regime of high monomer concentration. In fact, this phenomenon is rather universal and has a deep physical basis on
saturation. It is imaginable, in the presence of too many monomers competing for the same fibril end at the same time,
the fiber end will appear to be “saturated” since the incorporation of each monomer requires certain amount of time
and can not be finished at once. As a consequence, the elongation process appears to be blind to the instantaneous
monomer concentration in the system and shows a weaker-than-linear dependence.
Physically, the process of saturated elongation could be modeled through a “dock-lock” mechanism [116, 117], which
includes two sub-steps – unspecific attachment and detachment of a monomer with the fibril end, and subsequent
conformational change of the attached monomer to make the attachment specifically. Usually, the second process is
the rate-limiting step. For example, Scheibel et al. studied how nuclei mediate the conversion of soluble NM domain
of Sup35 to the amyloid form in the elongation phase of fiber formation [118]. By creating single-cysteine substitution
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mutants at different positions of NM domain to provide unique attachment sites for various probes, they estab-
lished that elongation is a two-step process involving the capture of an intermediate, followed by its conformational
conversion.
If we take Pbound and Pfree = P−Pbound as the number concentration of fibril ends which has and has not monomers
unspecifically attached, the “dock-lock” mechanism is expressed through following equations
d
dt
M = kcPbound, (49)
d
dt
Pbound = k
+
amPfree − k−a Pbound − kcPbound, (50)
where k+a , k
−
a and kc represent reaction rate constants for monomer unspecific attachment, detachment and confor-
mational change at the fibril end. It is clear that the three terms on the right-hand side of (50) account for the
contribution of each step mentioned in the “dock-lock” mechanism to fibril ends respectively.
To eliminate the additional variable Pbound, we refer to the classical Quasi Stead-State Approximation [119, 120],
which assumes the generation and consumption of Pbound are always in a dynamical equilibrium. Such that we can
take the sum of terms on the right-hand side of (50) to be zero, i.e.
0 = k+amPfree − k−a Pbound − kcPbound,
which gives solutions in a form of the famous Michaelis-Menten equation for enzyme kinetics [121],
Pfree = P
(
1 +
m
Km
)−1
,
Pbound = P
m
Km
(
1 +
m
Km
)−1
.
Here the Michaelis constant Km = (k
−
a + kc)/k
+
a .
Inserting above formula into (49), a simplified model incorporating the process of saturated elongation is reached,
d
dt
M = k+e mP
(
1 +
m
Km
)−1
, (51)
d
dt
P = knm
nc + k2m
n2M, (52)
in which the new rate constant for fiber elongation is defined as k+e = kc/Km = kck
+
a /(k
−
a + kc). Compared
to the formula in the section of fiber growth, a correction factor (1 + m/Km)
−1 has been added. Therefore, by
introducing an “effective” monomer concentration as m/(1 + m/Km), above model will recover the classical one
without saturation. Furthermore, if monomer concentration is much higher than the critical saturation concentration
(given by the Michaelis constant Km) m  Km, the effective monomer concentration becomes a constant Km;
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otherwise if the monomer concentration is much lower than the critical saturation concentration m Km, the effective
monomer concentration approaches to the real monomer concentration. In this way, both the linear dependence of
fiber elongation rate in the regime of low monomer concentration and sub-linear dependence in the high regime could
be explained by a unified picture based on saturated elongation. And the Michaelis constant Km serves as a key to
characterize the transition from linear to sub-linear (Fig. 11A and 11B).
The model for saturated elongation is far more difficult to solve than the classical one without saturation. In the
absence of initial seeds, a suggested practical solution is (unpublished result)
M(t) = mtot
{
1−
[
1 +
1
θ
y(1 + y)α/(1+α)
]−θ}
, (53)
where y = eκt/
√
1+α, α = mtot/Km, θ =
√
2/[n2(n2 + 1)] and κ =
√
k+e k2m
n2+1
tot . A critical concentration of fibrils
M(0)/mtot =  = k
+
nm
nc−n2−1
tot /(2k2) 1 has been introduced to seed the system, so that the resulting expression for
M(t) matches the leading order term for early time. In the special case of n2 = 0, which corresponds to fragmentation,
the solution reduces to
M(t) = mtot
{
1− e
[
− y(1 + y)α/(1+α)
]}
, (54)
by exploiting the identity limb→∞(1 + a/b)b = ea. Meanwhile, we have
P (t) =
√
θ2 + αϑ2κ
2k+
[
1−
(
m
mtot
)1/θ]
, (55)
where ϑ =
√
2/[(n2 + 1)(n2 + 2)]. Again, we need to pay attention to the case n2 = 0, which gives
P (t) =
1
2
knm
nc
tott+
k2mtot
κ
ln
(
1 + y
1 + 
)
. (56)
Based on above solutions, we can roughly determine the half time and the apparent fiber growth rate as
t1/2 ∼ ln(1/)
√
1 + α/κ, (57)
kapp ∼ κ/
√
1 + α. (58)
It is easily seen that t1/2 ∝ m−(n2+1)/2tot in the regime of low monomer concentrations mtot  Km and t1/2 ∝ m−n2/2tot
in the regime of high monomer concentrations mtot  Km. Especially, when n2 = 0 and mtot  Km, we have
t1/2 ∝ ln(1/mtot), which well explains the observed sub-linear dependence of fiber elongation under the condition of
high monomer concentrations.
In principle, all monomer-dependent processes may get saturated once the monomer concentration exceeds certain
threshold. And large amyloid proteins are more prone to get saturated than smaller ones under the same condition,
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FIG. 11: (A)-(B): Saturation of elongation rate for α-synuclein under different concentrations of soluble proteins and a constant
3.5µM seeds. Images are taken from [122]. (C)-(D): Saturation of surface catalyzed secondary nucleation for Aβ40 under various
monomer concentrations without initial seeds. Data fitting was performed according to (59) and (60) with k+e = 6×105M−1s−1,
kn = 2 × 10−6M−1s−1, k2 = 3 × 103M−2s−1, Ks = 6 × 10−6M , nc = n2 = 2. Images are taken from [88] with copyright
permission.
since the former generally requires a longer time to fit itself to the fibrillar structure. In view of saturation, the
model for surface catalyzed secondary nucleation (41) requires to be modified too (see Fig. 11C and 11D). Following
a similar “dock-lock” mechanism as well as derivations for saturated elongation, saturated secondary nucleation could
be formulated as
d
dt
P = knm
nc + k2
mn2
1 + (m/Ks)n2
M, (59)
d
dt
M = k+e mP, (60)
where Ks is the critical saturation concentration for secondary nucleation. Again, if monomer concentration is much
lower than the critical saturation concentration m  Ks, we will recover the classical model without saturation;
contrarily, if monomer concentration is much higher m  Ks, only a constant concentration of monomers Ks could
contribute to secondary nucleation due to saturation.
Self-iterative solutions in a similar form of (43) and (44) could be derived for above model through fixed-point
analysis. Interested readers may refer to [88] for details. Basically, everything is the same except k2 is replaced by
k2/[1 + (mtot/Ks)
n2 ]. Of particular interest is the scaling behavior of half-time, which are solved within logarithmic
corrections as t1/2 ≈ κ−1 ln(1/C+), where κ =
√
k+e k2m
n2+1
0 /[1 + (m0/Ks)
n2 ], C+ = k
+
e P0/(2κ) + k
+
e M0/(2m0k
+
e ) +
λ2/(2κ2), λ =
√
k+e knm
nc
0 . And m(0) = m0, P (0) = P0, M(0) = M0 are the monomer concentration, number and
mass concentration of seeds at the start of reaction respectively. Thus, in the presence of high monomer concentration
m0  Ks, we have t1/2 ∝ m−1/2tot , similar as that for the model of fragmentation; while in the regime of low monomer
concentration m0  Ks, the half-time t1/2 ∝ m−(n2+1)/2tot , which recovers the unsaturated case as expected. The
model combined both saturated elongation and saturated secondary nucleation is similar and will not be shown here.
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D. How to incorporate different conformations
It is well-known that the formation of amyloid fibrils is a direct consequence of the misfolding of amyloid proteins
[1, 123]. As an example, in one of the most well studied amyloid systems – prion, Prusiner identified that the
conformational conversion of prion protein from PrP to PrPsc gives rise to the famous mad cow disease and scrapie
in sheep [124]. In human, prion causes Creutzfeldt-Jakob disease (CJD) and kuru. According to the molecular size,
conformational conversion could be divided into either monomer conversion or oligomer conversion. While based on
the position where the conformational conversion happens inside the whole fibrillation procedure, it can be classified
into pre-, on-pathway and off-pathway conversion separately.
Among them, pre-conversion is a prerequisite for primary nucleation, elongation and surface catalyzed secondary
nucleation. It is directly related to monomer conversion and means the conformation of monomers has to be adjusted
in order to be incorporated into fibrillar structures [125, 126]. The kinetic modeling of conformational pre-conversion
is most straightforward. All terms concerning instantaneous monomer concentration m(t) in previous models should
be replaced by a new concentration of monomers in the unfolded (or partially unfolded) state mu(t) as required by
the fibrillar structure [127].
mu(t) =
∫ t
0
k+c m(τ)e
−(k+c +k−c )(t−τ)dτ +mu(0)e−(k
+
c +k
−
c )t, (61)
is the solution of
dmu
dt
= k+c (m−mu)− k−c mu, (62)
where k+c and k
−
c are the forward and backward reaction rate constants for protein conversion between the folded
and unfolded states. In practice, the effect of conformational pre-conversion is easily neglected due to the existence
of other rate-limiting steps, like primary nucleation. This fact is fully appreciated based on following argument.
If conformational conversion of monomers is faster than fiber growth rate, which is generally limited by primary
nucleation, we could assume monomers in the folded and unfolded states are in dynamic equilibrium and apply QSSA
approximation to obtain k+c (m−mu)− k−c mu = 0. By redefining k˜n = [k+c /(k+c + k−c )]nckn, k˜+e = [k+c /(k+c + k−c )]k+e ,
k˜2 = [k
+
c /(k
+
c + k
−
c )]
n2k2, the model in (41) and (42) is recovered without including conformational pre-conversion
explicitly.
In contrast to pre-conversion, objects of on-pathway and off-pathway conversion are both oligomers. Their main
difference lies on whether conformational conversion is necessary for fibril generation or not. In the on-pathway
conversion, oligomers need to take some rearrangements in structure, for example repacking from globular oligomeric
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conformation to linear fibril-like conformation, before growing into mature fibrils; while in the off-pathway conversion,
conformational conversion of oligomers will leads to amorphous aggregates in competition with fibrillar aggregates.
The kinetic modeling of on-pathway and off-pathway conversions is far more difficult than pre-conversion, due to the
conformational variety of oligomers, complicated interactions between oligomers, fibrils and amorphous aggregates
etc. Preliminary results for on-pathway conversion leading to fibrillary aggregates in transthyretin(TTR) [128], tau
proteins [129], insulin stabilized by Zn2+ [130] etc., and off-pathway conversion leading to the formation of amorphous
aggregates [60–62] could be found in literature. But details will be omitted with a pity.
Besides those well-formulated mechanisms discussed in current paper, there are still many processes, which play an
important role in changing the morphology of fibrils, affecting fibril thermodynamic stability, modifying fibrillation
kinetic profiles etc., worthy of exploring. For instance, Anderson et al. observed glucagon fibrils are able to generate
new fibril ends by continuously branching, which prefers an angle of 35o − 40o along the forward direction of parent
fibril and never occurs at the tip [131]. Murphy et al. further included lateral aggregation of filaments into fibrils
to build up a complete description of Aβ fibrillation [132]. Most importantly, in vivo conditions are completely
different from that in vitro [133, 134]. Not only the cellular crowding environment [135, 136], but also synthesis
[137], degradation [138] and transportation [139, 140] of amyloid proteins may exert a great impact on the fibrillation
kinetics. However, currently we still lack a quantitative characterization for most of them. These interesting topics
have to be left to the future with regrets.
E. How cytotoxicity arise
After looking into so many fibrillation mechanisms, we still have no idea about the most important issue, i.e. how
the aggregation of misfolded amyloid proteins affects normal cell function and gives rise to amyloidosis? To answer
this question, we first need to make sure which species of aggregates is responsible for cytotoxicity. For quite a long
time, mature fibrils have been taken for granted as the major cause of cell damage [2]. However, this view has been
challenged again and again in recent years, with accumulated evidences coming from the morphology, atomic structure
and functions of oligomers and fibrils both in vitro and in vivo [141, 142]. Now heterogeneous oligomers are generally
believed far more toxic than mature fibrils [143–145]. Meanwhile, solvable monomers are considered as less harmful
to cells even in a misfolded state [146, 147].
In literature, several mechanisms have been proposed for the molecular basis of cytotoxicity caused by oligomeric
species. Most arguments are based on the interaction between oligomers and lipid membrane. It is generally believed
36
0 1 2 3 4
M/
m t
ot
0
0.2
0.4
0.6
0.8
1.0
1.2
(A) Primary nucleation rate k
n
+
t(h)
0 0.1 0.2
P(μ
 
M)
10-5
10-3
10-1
101
0 1 2 3 4
0
0.2
0.4
0.6
0.8
1.0
1.2
(B) Elongation rate k
e
+
t(h)
0 1 2
0
0.5
1
1.5
0 1 2 3 4
0
0.2
0.4
0.6
0.8
1.0
1.2
(C) Elongation rate k
e
-
t(h)
0 1 2
0
0.2
0.4
0.6
0.8
0 1 2 3 4
0
0.2
0.4
0.6
0.8
1.0
1.2
(D) surface-catalyzed 
secondary nucleation rate k2 
t(h)
0 1 2 3 4
0
0.1
0.2
0.3
0.4
k
n
+ k
e
+
k
e
+
k
e
+
k
n
+
k
n
+
k
e
-
k
e
-
k
e
+
k
n
+
k2
k2k
e
-
k2
k2
k
e
-
0 2 4 6 8
M/
m t
ot
0
0.2
0.4
0.6
0.8
1.0
(E) Fragmentation rate kf
+
t(h)
0 1 2 3 4
P(μ
 
M)
10-5
10-4
10-3
10-2
10-1
0 2 4 6 8
0
0.2
0.4
0.6
0.8
1.0
(F) Fragmentation rate kf
-
t(h)
0 1 2 3 4
10-5
10-4
10-3
10-2
10-1
0 5 10 15 20
0
0.2
0.4
0.6
0.8
1.0
1.2
(G) Conversion rate k
c
+
t(h)
0 1 2 3 4
0
0.1
0.2
0.3
0.4
0.5
0 5 10 15 20
0
0.2
0.4
0.6
0.8
1.0
1.2
(H) Conversion rate k
c
-
t(h)
0 1 2 3 4
0
0.1
0.2
0.3
0.4
0.5
kf
+
kf
+
kf
+
kf
-
kf
-
kf
-
kf
+
kf
-
k
c
+
k
c
+
k
c
+
k
c
+
k
c
-
k
c
-
k
c
-
k
c
-
FIG. 12: Influence of rate constants on the fibrillation kinetics. In (A-C), rates for primary nucleation, elongation and monomer
dissociation are changed with respect to those in Fig. 9A (mtot = 18.4µM) by one or two orders of magnitude higher or lower.
The base line is drawn in black. Lines in purple and red mean increasing the parameter, while lines in green and blue mean
decreasing. In (D-H), similar procedures are performed on rates for monomer-dependent secondary nucleation, fragmentation,
annealing and monomer conversion respectively. To be exact, parameters in (D) are taken according to those for the first
subplot of Fig. 10 with mtot = 3.5µM ; parameters for (E) and (F) are the same as Fig. 9B with mtot = 11.5µM ; (G) and
(H) show a modified NE model by introducing an additional step of monomer conversion in (62). Besides k+c = 0.01s
( − 1),
k−c = 0.001s
( − 1), mtot = 18.4µM , other parameters are taken from Fig. 9A.
that the binding of oligomers could dramatically affect the shape and permeability of lipid membrane [148, 149],
induce undesired pores or ion-channel-like structures [150, 151], and give rise to fatal abnormal ion leakage therefore
[152, 153]. For instance, Demuro et al. observed in Xenopus oocytes that Aβ(1-42) oligomers can lead to abnormal
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Ca2+ flux independent of ion-channel from 5 to 40 mer [154]. Schauerte et al. further pointed out that hexamer is the
smallest stable oligomer that can penetrate cell membrane, whereas 12 to 14-mers give rise to the largest ion current
[155]. By MD simulation, Jang et al. proposed that 16- to 24-mers of Aβ arrange into pore-like structures [156],
which are compatible with the pores observed by atomic force microscopy [157, 158]. Meanwhile, Shafrir et al. found
that Aβ pores is an assembly made up of six hexamers [159].
Alternative hypothesis based on cellular regulatory network suggests that in vivo the exposed flexible hydrophobic
surfaces of oligomers can promote aberrant protein interactions, deregulate cytosolic stress response [160, 161], trigger
inflammatory responses, oxidative damage [162], alter kinase and phosphatase activities, increase neurofibrillary
tangles [147, 163, 164], change synaptic plasticity [165–168] and so on.
Recently, Hong and his colleagues extended kinetic models for amyloid fibrillation and included the cell damage
caused by oligomer formation too [169]. Four basic assumptions have been put forward as a general criterion for
modeling, i.e. (1) the basic procedure of amyloid formation is well formulated by kinetic models; (2) cell damage
is mainly caused by oligomers, rather than mature fibrils or monomers, through their binding to lipid membrane;
(3) cytotoxicity is quantified through the amount of membrane-bounded oligomers (or leaked ion concentration in
original manuscript); (4) oligomer binding does not affect the kinetics of amyloid formation. Or, in other words, the
consumption of oligomers during membrane binding could be neglected. The last assumption is generally unnecessary,
however mathematically it offers a simple way to get rid of the feed-back influence of oligomer consumption during
membrane binding and keep previous well-formulated equations of fibrillation kinetics unaffected.
Besides two equations for number concentration and mass concentration of aggregates P (t) and M(t), which char-
acterize the fibrillation process under difference mechanisms in previous sections, the concentration of cells in different
states, classified based on the number of membrane-bounded oligomers, evolves according to
d
dt
[Cj ] = Poli(t)
N−1∑
i=0
k+b (i)[Ci]−
N∑
i=1
k−b (i)[Ci], j = 0, · · · , N (63)
where [Ci] is the concentration of cells in state i, in which the lipid membrane has been bounded with i oligomers.
The current definition of cellular state is quite natural, since the condition of cell damage is positively correlated with
the amount of bounded oligomers according to assumption (3) above. The total cell concentration ctot =
∑N
i=0[Ci] is
a constant, in which N stands for the maximal number of oligomers allowed to be bounded to the same membrane.
k+b (i) and k
−
b (i) are rate constants for oligomer binding and unbinding, which potentially depend on the cellular
state. According to [170, 171], k+b ∼ (2 − 5) × 105M−1s−1 and k−b ∼ 5 − 300s−1 on average. Poli(t) is the number
concentration of oligomers at time t and can be expressed as a function of M(t) and P (t) according to the moment-
38
closure method shown in section of how to coarse-grain model. However, it is still uncertain whether Moli (the mass
concentration of oligomers) or even more complicated functions are required to include those toxic species and their
relative damage to cells explicitly.
Especially, a simple two-state model including only normal and damaged cells is obtained when N = 1, based on
which the fraction of damaged cells is given by
[C1]/ctot =
∫ t
0
k+b Poli(τ)e
{
−
∫ t
τ
[k+b Poli(σ)− k−b ]dσ
}
dτ. (64)
Once the time course for Poli(t) is determined through the fibrillation kinetics, a full knowledge about the progress
of cell damage caused by oligomers binding could be obtained. A similar approach by examining the leaked ion
concentration has been adopt by Hong et al. [169] and applied to β2m and IAPP fibrils induced membrane leakage
with great success (see Fig. 13).
FIG. 13: hIAPP fibril growth and hIAPP-induced membrane leakage: (A) fibril mass concentration measured by ThT fluores-
cence; (B) the amount of membrane leakage under different initial protein concentration; (C) the half-time for fibril formation
and membrane leakage; and (D) the amount of membrane leakage under different concentrations of seeds. Image is taken
from [169] with copyright permission, but all fittings are re-performed according to (63) with k+n = 4 × 10−5M−1s−1, k+e =
1.2×105M−1s−1, k−e = 0s−1, k+f = 7×10−5s−1, k−f = 1×104M−1s−1, k+b = 1.5×105M−1s−1, k−b = 2.5×10−3s−1, n = 1, nc =
2, no = 40. Particularly, in (D) mtot = 2.5× 10−5M,k+b = 6× 105M−1s−1, k−b = 1× 10−3s−1 and M(0)/P (0) = 400.
F. How to manipulate fibrillation
A central aim for examining various fibrillation mechanisms is to manipulate the kinetics of amyloidosis. Based
on different targets, there are basically two large groups of approaches to achieve this goal. The indirect approach
is to control the environment, in which amyloid fibrillation takes place. Here the word “indirect” means we will not
manipulate amyloid proteins or fibrils directly. Alternatively, by varying the temperature, pH value, salt concentration
etc., reaction rate constants for different processes will be changed accordingly. As a result, we can either accelerate or
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decelerate any given amyloid fibrillation, as well as increase or decrease the population of any oligomeric and fibrillar
species. To be concrete, by decreasing the elongation rate, monomers will be overpopulated; otherwise, the population
of mature fibrils will be enlarged. To increase the population of oligomers is a bit complex, which requires increasing
the rate of primary nucleation and decreasing that of elongation at the same time.
According to the classical transition state theory (TST) for elementary chemical reactions, the rate constant for a
given process is determined by the Arrhenius equation [172, 173]
k = A exp[−Eact/(kBT )], (65)
where A is referred to as the frequency factor, and E is regarded as the activation energy, which in principle is a
function of various experimental conditions, Eact = Eact(temperature, pH value, salt concentration etc.). Therefore,
if we know how the activation energy for various elementary fibrillation processes relies on conditions quantitatively,
we can control the fibrillation kinetics as well as the population of each species freely as we wish.
Although for many cases the indirect approach is quite useful, it suffers some intrinsic limitations, e.g. it is difficult
to make a big change of some fibrillation conditions in experiments; some conditions may play a complex role in
determining the reaction rate and no quantitative or qualitative description is available; in many cases, changing one
condition may affect almost all processes at the same time, which makes it almost impossible to perform analysis.
The direct approach means to manipulate the concentration of each species directly. Varying the initial monomer
concentration and seeds concentration are two most popular and effective methods in vitro, whose effects on fibril-
lation kinetics and species populations have been fully appreciated in previous sections. In vivo, directly adding or
removing monomers and seeds becomes less promising. Therefore, specific binding through antibodies and chaperons
is introduced to control the fibrillation kinetics as well as species population.
Antibodies and chaperons are both well-known for their specificity in binding to certain molecular structures. In
principle, we can diminish any monomeric, oligomeric and fibrillar species by introducing proper antibody or chaperon
into the system, which therefore allows us to manipulate each elementary fibrillation process independently. For
example, nano-particles have been widely used in literature to inhibit amyloid fibrillization, induce fibril dissociation
and mitigate neurotoxicity [174–176]. Similarly, many chaperon molecules, like Hsp70 family members, are known
for their ability to inhibit and reverse the formation of amyloid aggregates [177–179]. Now, searching for various
promising antibodies and chaperons to inhibit amyloid fibrillation, or to prevent and cure amyloidosis as a potential
goal, becomes very popular in this field (see Fig. 14 as an exmaple). Though in many cases, the molecular basis for
why it works has not yet been clarified.
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To mathematically probing various potential binding effects of antibodies (or chaperons) on amyloid fibrillation is
a systematic and laborious task, and has not been developed into a mature theoretical framework. Here we just look
into one particular example to show how to do it in principle. The mechanism of antibody blocking fibril ends and
stopping the elongation process could be formulated into
d
dt
[B] = −k+b Pfree[B] + k−b Pbound, (66)
d
dt
Pfree = knm
nc + k2m
n2M−k+b Pfree[B] + k−b Pbound, (67)
d
dt
M = k+e mPfree − k−e Pfree, (68)
where Pfree = P − Pbound and Pbound = btot − [B] are concentrations of free fibril ends and antibody blocked fibril
ends separately. [B](t) is the free antibody concentration at time t, and btot is the total concentration of antibodies,
which is conserved during reactions. k+b and k
−
b are rate constants for antibody binding and unbinding respectively.
In a similar way, antibody binding oligomers and blocking primary nucleation or secondary nucleation, chaperons
binding fibrils and reversing amyloid formation, etc. could be modeled and will not be addressed further.
In the presence of antibody or chaperon, model analysis becomes far more difficult. However, under one particular
condition interested in experiments, i.e. the rates for antibody (or chaperon) binding and unbinding are much faster
than the fibrillation speed, we can safely apply the Partial Equilibrium Approximation (PEA) to (66) and suppose
terms on the right-hand side cancelling each other at every moment, meaning −k+b [B]P + k−b (btot − [B]) = 0. Then
class results for P and M without antibody binding are recovered. This leads to an important conclusion that, in
order to manipulate amyloid fibrillation, the rate for antibody unbinding must be slower than that of fibrillation.
FIG. 14: Brichos slows down Aβ42 aggregation by inhibiting the surface catalyzed secondary nucleation. (A)-(C): From left
(blue) to right (green), 0%, 10%, 15%, 35%, 50%, 75% and 100% Aβ42 monomer equivalents of Brichos have been added
respectively. The concentration of monomeric Aβ42 is 3 µM. (D)-(F): The blue line corresponds to the situation in the absence
of Brichos. The green dashed lines in (D)-(F) respectively show predictions for the cases in which primary nucleation, elongation
and secondary nucleation are inhibited. Image is taken from [180] with copyright permission.
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G. Summary
The fibrillation kinetics is a central issue in the study of amyloidosis and amyloid diseases. In the past several years,
fruitful results and plenty of deep physical insights have been obtained in this direction. Among them, mathematical
modeling based on chemical mass-action equations offers a unified framework to treat this problem. In the current
section, we focus on how to apply kinetic modeling to explain various kinetic phenomena we have observed in real
amyloid systems, which could be characterized and classified according to the half-time and fiber apparent growth
rate as shown in Table I. Actually, the scaling relations between half-time of fibrillation (or fiber apparent growth
rate) and monomer concentration provide us a useful way in practice to pick out the proper model, to classify amyloid
systems based on their own fibrillation mechanisms (see Fig. 15) etc.
Mechanism t1/2 kapp parameters
NE λ−1 λ λ =
√
knk
+
e m
nc
tot
NES κ−1s ln(κs/λ) κs κs =
√
k+e k2m
n2+1
tot
NEF κ−1f ln(κf/λ) κf κf =
√
k+e k
+
f mtot
NE*
√
1 + αλ−1 λ/
√
1 + α α = mtot/Km
NE*S
√
1 + ακ−1s ln(κs/λ) κs/
√
1 + α
NE*F
√
1 + ακ−1f ln(κf/λ) κf/
√
1 + α
NES*
√
1 + βκ−1s ln(κs/λ) κs/
√
1 + β β = (mtot/Ks)
n2
NE*S*
√
(1 + α)(1 + β)κ−1s ln(κs/λ) κs/
√
(1 + α)(1 + β)
seeded E ν−1 ν ν = k+e P0
seeded E* αν−1 ν/α
TABLE I: A summary of half-time and apparent fiber growth rate under different fibrillation mechanisms. Capital E stands for
elongation, S for surface catalyzed secondary nucleation, F for fragmentation and ∗ for saturation of corresponding processes.
“Seeded” means conditions with pre-added seeds. In general, fragmentation can be regarded as a special case of secondary
nucleation with n2 = 0.
IV. MATHEMATICAL AND APPLICATION FOUNDATIONS
The former section is wholly based on macroscopic kinetic models for the mass concentration and number concen-
tration of fibrils, but why we can adopt this simple picture and how its accuracy is compared to models at a molecular
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FIG. 15: Scaling relationships between kapp, t1/2, and mtot for eight fragmentation dominated amyloid proteins, i.e. the yeast
prion Sup35 NW region (purple triangles up), Csg Btrunc (red squares), Ure2 protein (cyan pentacles), β2-microglobulin (brown
stars), stefin B (blue cross), α-synucleins (black triangles down), WW domain (yellow circles), and insulin (green diamonds).
Image is taken from [127] with copyright permission.
lever have never been addressed. For this purpose, here we are going to the mathematical foundation of kinetic mod-
eling, in which the mathematical linkage between models at the microscopic scale (molecular lever) and macroscopic
scale (what we adopted in the former section) will be clarified in quantity. Interestingly, this linkage provides us ways
to reconstruct the full fiber length distribution from a knowledge of mass concentration and number concentration
of fibrils in a high accuracy, which is generally believed to be very difficult as an inverse problem. Finally, issues on
how to convert model predictions into experimental observations, how to determine unknown model parameters and
how to perform reliable global fittings are discussed too, in order to provide a relatively comprehensive review on the
kinetic aspect.
A. How to quantify fibrillation kinetics
In order to quantify the kinetics of amyloid fibrillation, let’s introduce the fiber length distribution {[Ai], i ≥ 1}, each
of whose components represents the concentration of aggregates containing exactly i protein molecules. Especially,
muiv[A1] stands for the concentration of monomers. According to different reaction schemes for amyloid aggregation
which we have addressed in details in the main text, the time evolution of {[Ai](t)} will be characterized through a
group of coupled ordinary differential equations (without taking the spacial distribution into consideration) by using
laws of mass-action. This leads to the so-called “microscopic chemical kinetic equations”, since they contain a full
knowledge of the fiber length distribution.
On the other hand, either due to resolution limitation of experiments which makes it impossible to obtain a full
spectrum of fiber length distribution, or for a purpose to speed up simulation without taking too many details into
consideration, a simple coarse-grained description is preferred. Among various candidates, formulation involving two
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macroscopic quantities – the number concentration and mass concentration of aggregates (including both oligomers
and fibrils)
P =
∞∑
i=nc
[Ai], M =
∞∑
i=nc
i · [Ai], (69)
where nc stands for the critical nucleus size, is the most popular and welcomed. A basic reason is that this formulation
actually provides a simplest self-consistent way to examine the amount of amyloid fibrils formed inside a given system,
a quantity we are most interested in.
From above definition, we can see that P and M are actually the zeroth and first-order moments of fiber length
distribution {[Ai]} for i ≥ nc. The total mass concentration mtot =
∞∑
i=1
i · [Ai] is another often used first-order moment.
In particular, if oligomer concentration [Ai] (2 ≤ i ≤ nc − 1]) could be neglected, we will have mtot = m(t) + M(t),
an equality representing the mass conservation of total protein molecules during fibrillation. In principle, other high
order moments could also be introduced into the formulation in order to achieve a high accuracy, but in many cases
it is not very worthwhile due to the sacrifice of both simplicity and efficiency. In literature, the governing equations
of moments are referred to as “macroscopic chemical kinetic equations” in contrast to microscopic formulation based
on fiber length distribution.
The relation between macroscopic and microscopic chemical kinetic equations is an interesting question. In fact, a
whole branch of statistical physics is dealing with such problems on how to derive macroscopic quantities and their
governing kinetic equations from a knowledge of microscopic descriptions [181]. There are enormous investigations,
fruitful results and endless debates in history which are far beyond the scope of this paper. But on current specific
topic, almost all issues could be solved by some well-formulated moment-closure methods. We will come back to this
point with all necessary details in the next section.
At last, we want to introduce the half time of fibrillation t1/2 and the apparent fiber growth rate kapp [127], i.e.
M(t1/2) =
M(0) +M(∞)
2
, kapp =
1
mtot
dM
dt
∣∣∣∣
t=t1/2
. (70)
These two quantities are essential to characterize the kinetics of amyloid fibrillation in an empirical way (see (89)),
even without referring to any models or analytical solutions. Two additional quantities appear in literature from time
to time too. One is the lag time, which is defined as tlag = t1/2 − 1/(2kapp). The lag time has an intuitive physical
meaning, which measures how long an amyloid system has to wait in order to accumulate enough seeds to pass the
phase dominated by primary nucleation. In the presence of secondary nucleation, the lag time becomes prominent
due to the sigmoid fibrillation profile, and could be greatly shortened by an introduction of initial seeds. There are
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also other ways to define the lag time in literature, e.g. the time when the mass concentration of aggregates reaches
1% of its static value [182]. Obviously, our definition is more natural and meaningful in physics. The other quantity is
related to the speed of fibril growth, its maximal value to be exact. However, in most cases the maximal fiber growth
rate kmax relies on the whole fibrillation profile, which makes it difficult to determine and use.
B. How to coarse-grain model
In last section, we have introduced the fiber length distribution and its moments in different orders, like the number
concentration and mass concentration of aggregates. We have also claimed there is a direct connection between the
macroscopic and microscopic chemical kinetic equations. Now we are going to address this point based on the method
of moment closure.
Without loss of generality, we consider the reaction scheme proposed for the length-dependent fragmentation [111].
According to laws of mass-action, the time evolution of fiber length distribution obeys following equations
d[A1]
dt
= −nck+n [A1]nc + nck−n [Anc ]− k+e [A1]
∞∑
j=nc
[Aj ] + k
−
e
∞∑
j=nc+1
[Aj ], (71)
d[Ai]
dt
= k+e [A1]([Ai−1]− [Ai])− k−e ([Ai]− [Ai+1]) + 2
∞∑
j=nc+i
k+f (i, j − i)[Aj ]
−
i−nc∑
j=nc
k+f (j, i− j)[Ai]− 2
∞∑
j=nc
k−f (i, j)[Ai][Aj ] +
i−nc∑
j=nc
k−f (j, i− j)[Aj ][Ai−j ]
+(k+n [A1]
nc − k−n [Ai]− k+e [A1][Ai−1] + k−e [Ai])δi,nc , i ≥ nc. (72)
As a consequence, it is straightforward to show that the number concentration P (t) and mass concentration M(t) of
aggregates evolve according to
d
dt
P = k+n (mtot −M)nc − k−n [Anc ] +
∞∑
i=nc
∞∑
j=i+nc
k+f (i, j − i)[Aj ]−
∞∑
i=nc
∞∑
j=nc
k−f (i, j)[Ai][Aj ], (73)
d
dt
M = nck
+
n (mtot −M)nc − nck−n [Anc ] + k+e (mtot −M)P − k−e P + k−e [Anc ], (74)
which clearly are not closed, as unknown variables {[Ai]} have not been expressed through P and M .
To solve this problem, a systematic moment closure method based on Maximum Entropy Principle [112, 113] has
been proposed and applied with great success [111, 169, 183] (as shown in Fig. 16). Namely, we seek for solutions of
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following constrained optimization problem, i.e.
max S({[Ai]}) = −kB
∞∑
i=nc
([Ai] ln[Ai]− [Ai]), (75)
s.t.
∞∑
i=nc
[Ai] = P,
∞∑
i=nc
i · [Ai] = M, [A1] +
∞∑
i=nc
i · [Ai] = mtot. (76)
It could also be translated into an equivalent variational problem through the method of Lagrangian multiplier,
δ
δ[Ai]
[
S({[Ai]})/kB + λ1
( ∞∑
i=nc
[Ai]− P
)
+ λ2
( ∞∑
i=nc
i · [Ai]−M
)
+ λ3
(
[A1] +
∞∑
i=nc
i · [Ai]−mtot
)]
= 0, (77)
where λ1, λ2 and λ3 are Lagrangian multipliers. The solution of above equation is given by
[A1] = e(λ3), (78)
[Ai] = e[λ1 + i(λ2 + λ3)], (79)
based on which λ1, λ2 and λ3 are related to P (t), M(t) and mtot as
λ1 = ln
[
P 2
M − (nc − 1)P
]
− nc ln
[
M − ncP
M − (nc − 1)P
]
, (80)
λ2 = ln
[
M − ncP
M − (nc − 1)P
]
− ln(mtot −M), (81)
λ3 = ln(mtot −M). (82)
Put these formulas back into (73) and (74), we obtain desired macroscopic chemical kinetic equations solely concerning
with P (t) and M(t).
In [111], it has been proven that above moment closure method based on Maximum Entropy Principle is mathe-
matically equivalent to Partial Equilibrium Approximation on fiber elongation, which assumes the elongation process
is much faster than primary nucleation and fragmentation. Therefore, for given number concentration P (t) and mass
concentration M(t) of aggregates, each component of fiber length distribution {[Ai]} is considered in quasi-equilibrium
with each other, which is exactly the way how we are able to express [Ai](t) as a function of P (t), M(t) and mtot.
C. How to reconstruct fiber length distribution from moments
In previous section, we have focused on how to simplify the model by coarse-graining, which turns out to be a very
promising approach with tremendous successful applications. However, during coarse-graining, we are facing with
an inevitable loss of information. Original knowledge of full fiber length distribution has been compressed into that
about only two macroscopic moments – the number and mass concentration of aggregates to be exact. Is it possible
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FIG. 16: Accuracy of moment-closure method through comparisons on the fiber mass concentration, number concentration and
fiber length distribution in (A-C). Values obtained from microscopic kinetic equations (71) and (72) are drawn in circles and
that from moment-closure methods in solid lines. (D) Application to the polymerization of WW domain. Image is taken from
[111] with copyright permission.
to reconstruct original fiber length distribution based on a knowledge of these two moments? This is a question not
only of mathematical interest, but also with great practical usage. In principle, inverse problems are generally very
difficult to solve and do not admit a unique solution [184–186]. But, in current case without considering filaments
fragmentation and annealing, as we are so lucky to have a complete understanding about underlying microscopic
processes, the full fiber length distribution at any time could be explicitly extracted just from one moment – mass
concentration of aggregates as well as some knowledge about the initial length distribution. A brief derivation is listed
as follows.
Without loss of generality, let us start with following microscopic model, including primary nucleation, elongation
and secondary nucleation [187],
d[Ai]
dt
= k+e m(t)([Ai−1]− [Ai]) + knm(t)ncδi,nc + k2m(t)n2
[
mtot −m(t)
]
δi,n2 , i ≥ nc (83)
where n2 ≥ nc > 0. Introduce the generating function [188]
C(z, t) =
∞∑
j=nc
zj · [Aj ](t), (84)
which is a natural mathematical generalization of the physical moments. Especially, we have P (t) = C(z = 1, t) and
M(t) = ∂C(z,t)∂z |z=1. In fact, the ful fiber length distribution could be recovered from the generating function, i.e.
[Aj ](t) =
1
j!
∂jC(z,t)
∂zj
∣∣
z=0
for i ≥ nc, which means the generation function is a one-to-one mapping of the fiber length
distribution.
It is straightforward to show that the generating function satisfies following equation
∂C(z, t)
dt
= k+e m(t)(z − 1)C(z, t) + knm(t)ncznc + k2m(t)n2 [mtot −m(t)]zn2 . (85)
Define a new time scale τ(t) =
∫ t
0
k+e m(s)ds, which acts as the characteristic time for fiber elongation, above equation
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could be rewritten as
∂C(z, τ)
dτ
= (z − 1)C(z, τ) +
{
knm(τ)
ncznc + k2m(τ)
n2 [mtot −m(τ)]zn2
}
∂t
∂τ
, (86)
whose solution is given by
C(z, τ(t)) =
∫ t
0
e−(z−1)[τ(s)−τ(t)]
{
knm(s)
ncznc + k2m(s)
n2 [mtot −m(s)]zn2
}
ds+ C(z, 0)e(z−1)τ(t). (87)
Now the fiber length distribution at any given time t could be calculated through following formula
[Aj ](t) =
1
j!
∂jC(z, t)
∂zj
∣∣∣∣
z=0
=
∫ t
0
Θj−nc(t, s)knm(s)
ncds+
∫ t
0
Θj−n2(t, s)k2m(s)
n2 [mtot −m(s)]ds
+
j∑
k=nc
Θj−k(t, 0)[Ak](0), (88)
where τ(t) =
∫ t
0
k+e m(s)ds and Θk(t, s) = e
τ(s)−τ(t)[τ(t)− τ(s)]k/k!. During the calculation, we use identities 00 = 1
and 0! = 1.
Above formula provides the mathematical foundation on how to extract the full fiber length distribution at any
time just based on the time course of monomer concentration (or mass concentration of aggregates M(t)) as well as
the initial fiber length distribution. This is a quite astonishing result, as we have mentioned that inverse problems
are usually extremely difficult to solve and do not admit a unique solution in general. Our success in this case could
be contributed to two reasons: one is we have a complete knowledge on the microscopic kinetics which governs the
time evolution of fiber length distribution; the other is both primary nucleation and secondary nucleation can solely
affect the concentration of single species [Anc ] or [An2 ]. The only way to perform a global change of the fiber length
distribution is elongation, which follows a Poisson process characterized by the integral kernel Θk(t, s) with intrinsic
time scale τ(t) =
∫ t
0
k+e m(s)ds, since each monomer association is obviously random and independent of each other.
In the presence of filaments fragmentation and annealing, an additional global change of the fiber length distribution
will be introduced besides elongation. How to include these two processes into above picture explicitly is an unsolved
problem. In particular, Michaels et al. derived approximate solutions for length-independent fragmentation in open
and close systems [189]. While for general models with length-dependent fragmentation and annealing, an empirical
method has been proposed, whose theoretical foundation lies on the fact that during the procedure of moment-closure,
the microscopic fiber length distribution is expressed through macroscopic moments based on Maximum Entropy
Principle. The thus obtained fiber length distribution directly determines the accuracy of macroscopic equations,
which as a consequence could be adopted as an empirical candidate to approximate the exact fiber length distribution
without introducing new errors. This empirical approach has been applied to examine a fragmentation-only model
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and matches perfectly with numerical solutions and experimental data for fiber-like PI264-b-PFS48 micelles under
sonication as shown in Fig. 17 [183]. In addition, similar procedure has been shown effective for a more complicated
model, including primary nucleation, elongation and length-dependent fragmentation [190].
FIG. 17: Accuracy of approximate fiber length distribution constructed from moment-closure method for a fragmentation-
only model. Comparisons were made among TEM measurements of fiber-like PI264-b-PFS48 micelles under sonication (black
symbols), exact fiber length distribution in (71) and (72) (red solid curves), and approximate fiber length distributions (brown
and blue dashed curves). Image is taken from [183]) with copyright permission.
D. How to make a connection to experiments
According to Nilsson [191], there are three criteria that define a protein aggregate as an amyloid fibril: green
birefringence upon staining with Congo Red, fibrillar morphology, and β-sheet secondary structure. Based on these
three criteria, plenty of novel instruments and techniques have been developed to probe amyloid fibrils and their
kinetics. Instead of providing a comprehensive review on each technique, like its basic setup, procedure and protocols,
advantages and limitations, we will focus on the relation between those physical quantities we can measure and
mathematical quantities we have defined for characterizing the fibrillation kinetics.
The most widely adopted technique to monitor the fibrillation kinetics is Thioflavin T (ThT) fluorescence. When
it binds to β-sheet-rich structures, like those in amyloid aggregates, the dye displays enhanced fluorescence and a
characteristic red shift of its emission spectrum [192, 193]. It has been shown that: (1) the ThT fluorescence intensity
increases nearly linearly with the total amount of amyloid fibrils for several orders of magnitude; (2) the fluorescence
intensity is independent of number concentration of amyloid fibrils if mass concentration is constant; (3) if the number
concentration is fixed as in the extension kinetic study, the increase of average length of amyloid fibrils corresponds to
an increase in the fluorescence intensity too [194, 195]. These features make ThT fluorescence an unusually sensitive
and efficient reporter for the mass concentration of aggregates M(t), despite of limitations that ThT is not perfectly
specific for amyloid fibrils, as well as some amyloid fibrils do not affect the fluorescence. In experiments, following
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empirical formula is often used to interpret the fluorescence intensity observed during amyloid fibrillation [104],
F (t) = F (0) +
A
1 + e[−kapp(t− t1/2)] , (89)
where F (t) is the fluorescence intensity at time t, F (0) is the background fluorescence intensity at the starting time,
and A is a fitting constant to correlate the mass concentration of aggregates with the absolute fluorescence intensity.
Based on above formula, we can easily extract the apparent fiber growth rate kapp and half-time of fiber formation
t1/2 from data fitting.
The goal of any absorption spectroscopy, e.g. Fourier transform infrared (FTIR) spectroscopy, ultraviolet-visible
(UV) spectroscopy, circular dichroism (CD) etc., is to detect the presence of certain molecular structure by measuring
the light absorbed at each wavelength. It has been established that, in FTIR, a peak near 1645cm−1 indicates
random coil, 1655cm−1 for α-helix and 1620 − 1640cm−1 for β-sheet [196]; while in far-ultraviolet (170 − 250nm)
circular dichroism, a pronounced double minimum at 208 and 222nm indicates α-helical structure, and a single
minimum at 204nm or 217nm reflects random-coil or β-sheet structure [197, 198]. Thus we can make a quantitative
correlation between the fraction of certain structure (say β-sheet as an indicator of amyloid fibrils) with absorbed
light intensity at the corresponding wavelength. Here we take the CD spectroscopy as a simple example, in which the
fraction of β-sheet structure could be expressed through the measured ellipticity as [199]
Cbeta
Cbeta + Ccoil
=
Θobs217 −Θ0217
Θmax217 −Θ0217
, (90)
where Θ0217 is the ellipticity at 217nm at the beginning of time; while Θ
obs
217 and Θ
max
217 represent observed and maximal
ellipticity at 217nm during the whole measurement. Cbeta and Ccoil represent the concentration of β-sheet and random
coil structures separately.
Instead of light absorption, dynamic light scattering (DLS) is a technique that can be used to determine the size
distribution profile of small particles in suspension or polymers in solution [200]. Although light scattering by particles
in solution depends on a number of factors, the most relevant one is the ratio of particle size with respect to quantity
λ/[2pi sin(θ/2)], where λ is the wavelength of incident light and θ is the angle of detection [132, 201]. As the average
length of amyloid fibrils is expected to get larger during amyloid fibrillation, the intensity of light scattered by fibrils
will be directly proportional to the mass concentration of aggregates [62, 202],
Iscat(t) =
QλM(t)
4l sin(θ/2)
, (91)
where l is the monomer size, Q is a constant depending on the setup.
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Currently, transmission electron microscopy (TEM), atomic-force microscopy (AFM) and scanning-force microscopy
(SFM) are most advanced techniques with highest resolution. According to [203], the smallest distance that can be
resolved with a TEM is approximately 0.2−0.5nm and, for STM, a typical resolution of several tenths of one nanometer
can be achieved. In comparison, the diameter of typical filaments is around 3− 4nm and 8− 10nm for mature fibrils,
while the length may vary from hundreds of nanometers to a few micrometers [204–206]. Therefore, we may use
those instruments to directly observe the growth, inhibition, propagation and adaptation of single fibril and even its
breakage and branching in real time [131, 207–209]. With high-resolution images in hand, the fiber length distribution
could be extracted to certain accuracy, based on which both the number concentration and mass concentration of
aggregates could be obtained. As a conclusion, advanced high-resolution microscopies could provide us most detailed
information about amyloid fibrils, both their morphology and kinetics, though at an great expense of money and time.
E. How to determine model parameters
How to determine unknown parameters is a key step in model application. Although it is as important as modeling
itself, details behind parameter fitting have seldom been clarified. A major obstacle is that usually most model
parameters are empirical and hard to be precisely determined by either experiments or fundamental principles in
nature. Their accuracy and validity heavily depends on the experience of modelers.
Here we face with the same problem. In current study, the parameters, we adopted for describing amyloid fibrillation,
cell damage and antibody inhibition in the main text, can be roughly divided into four groups.
The initial protein concentration mtot, mass concentration M0 and number concentration P0 of initial seeds, total
cell concentration ctot and antibody concentration btot are generally pre-specified in the setup. They are not adjustable
during the fitting and can be classified into Group I.
Group II contains those application-insensitive parameters, like the critical nucleus size nc, the monomer disassoci-
ation rate k−e and filaments annealing rate k
−
f in some cases. Since their values have a minor influence on the model
performance, according to Occam’s Razor, they can set to a default value (usually nc = 2 and k
−
e = k
−
f = 0). In
mathematics, sensitivity analysis allows a systematical determination of model parameters in this group.
Group III contains those parameters which can be determined either by experiments or by some fundamental
principles. For example, as discussed in section of how fibrils grow, the fiber elongation rate k+e for different amyloid
proteins has been measured by plenty of techniques in recent years. We can directly take their values from the
literature giveing the same amyloid protein under similar experimental conditions.
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The last group includes those freely adjustable model parameters. In most cases, the primary nucleation rate kn,
critical nucleus size n2 and rate k2 for surface-catalyzed secondary nucleation, fiber fragmentation rate k
+
f are essential
for modeling the fibrillation kinetics, and oligomer binding and unbinding rates k+b and k
−
b for modeling cell damage.
The first four parameters can be gotten by performing global fitting of amyloid formation, while the last two are
determined through data on cytotoxicity (a sensitivity analysis of model parameters could be learned from Fig. 18).
In this sense, there will be no free tunable parameter left.
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FIG. 18: Model sensitivity on six adjustable parameters. The baseline values are taken in accordance with those in Fig. 13B.
All six reaction rates are changed by either two times or one half with respect to their baseline values separately.
F. How to perform global fitting
As claimed by John von Neumann, “With four parameters I can fit an elephant, and with five I can make him
wiggle his trunk.” An over-fit of experimental data with too many undetermined model parameters is encountered
from time to time. Although a great effort has been dedicated to eliminate unnecessary model parameters as shown
in last section, we are still facing with the problem how to perform a fitting reasonably and robustly. Global fitting,
as suggested by its name, provides a nice way to partially solve this difficulty and make the fitting more reliable and
promising.
The central idea of global fitting is to try to fit all data at the same time with the same parameters. In a such
way, the redundancy in model parameters could be eliminated as much as possible and those key parameters will be
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highlighted. Although, the requirement of global fitting is quite natural from a theoretical view, in practice it is not
so easy to perform it. One obstacle is data noise. In the presence of large noise, a global fit becomes impossible, which
means we have to either try best to eliminate noise source and perform measurements as precisely as possible, or
include the influence of noise into modeling at the beginning (e.g. stochastic models). Another obstacle comes from
the high dimensionality of the parameter space. Efficient global exploration methods, applicable to high dimensional
space, has to be implemented during the procedure of fitting. In contrast, local exploration methods or those only
valid for low dimensional space are not applicable. Finally, quantitative judgements or scores are needed in order to
tell which group of model parameters gives the best fitting.
For this purpose, programs for global fitting have been developed for the kinetic models we have discussed in the
main text [210]. Various global exploration methods, such as simulated annealing, genetic algorithm, particle swarm
method ect., have been implemented into the program to avoid local trapping (private codes). Generally speaking,
according to our own experience, simulated annealing is efficient and reliable in most cases; genetic algorithm consumes
the longest CPU time among the three; while particle swarm is also quite slow, but in some cases it gives better results
than simulated annealing. In these programs, nonlinear least-square regression is adopted to minimize the sum of
squared errors between experimental data and those predicted by the model. Now we plan to take the influence of
noises on global fitting into consideration. Related works are going on.
V. CONCLUSION
In the past decades, due to the increasing interest on amyloid related diseases, a variety of amyloid proteins and
their fibrillation processes have been investigated in details. In this self-contained reviewed, fruitful results on both
thermodynamics and kinetics of amyloid fibrillation have been shown and discussed, with a purpose to provide a
relatively comprehensive physical picture on what we know and what we do not know in this field. As a summary,
facts we have learned from thermodynamic and kinetic modeling are:
1. The existence of a critical fibrillar concentration below which fibrillar mass is negligible;
2. Above the critical fibrillar concentration, the length distribution of the fibrils is exponential. This remains so
even in the semi-dilute limit, if the fibril-fibril interactions are purely steric;
3. If the fibrils exhibit attractive lateral interactions, there will be a strong tendency for phase separation of fibrils;
4. Molecular mechanisms of amyloid fibrillation could be formulated into a group of microscopic chemical kinetic
53
equations concerning with fiber length distribution;
5. Low-order moments, a function of fiber length distribution, evolves according to macroscopic chemical mass-
action equations derived by moment-closure method;
6. Mass concentration and number concentration of aggregates are two most widely used moments and provide a
well characterization of fibrils;
7. In many cases, fiber length distribution could be reconstructed from moments exactly or approximately once
the underlying fibrillation kinetics is known;
8. Primary nucleation, elongation and secondary nucleation, including monomer-independent fragmentation and
monomer-dependent surface catalyzed secondary nucleation, constitute a basic framework for amyloid fibrilla-
tion, which has been applied to many amyloid systems successfully;
9. Conformational conversion of monomeric, oligomeric and fibrillar structures is crucial for amyloid fibrillation
but easily neglected in kinetic modeling due to other rate-limiting steps;
10. Effect of high monomer concentration on fiber elongation and surface catalyzed secondary nucleation could be
explained by saturation;
11. Oligomers binding to lipid membrane play a key role in cytotoxicity and can easily included in kinetic models;
12. Quantitative knowledge on how to manipulate amyloid species and fibrillation kinetics could be learned from
kinetic modeling, which provides us a power method to probe amyloidosis.
In our opinion, answering the following questions would constitute fruitful research direction:
1. How to incorporate various morphologies of amyloid fibrils into the thermodynamic picture?
2. How to construct a complete picture of phase separation and transition for amyloid fibrillation?
3. How to include oligomeric species explicitly in kinetic models?
4. How to model lateral association of protofibrils or filaments into mature fibrils, like coiling and twisting?
5. How to determine various reaction rate constants under a given fibrillation condition?
6. How to systematically quantify the effect of antibody and chaperon in order to manipulate amyloid fibrillation?
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7. How to correlate amyloidosis with their fibrillation mechanisms at a molecular level?
8. How to probe amyloid diseases with kinetic modeling?
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